(375982, 'HP:0004396', 'Poor appetite', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375983, 'HP:0004396', 'Poor appetite', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375984, 'HP:0004396', 'Poor appetite', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375985, 'HP:0004396', 'Poor appetite', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375986, 'HP:0004396', 'Poor appetite', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375987, 'HP:0004396', 'Poor appetite', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375988, 'HP:0004396', 'Poor appetite', 'MP:0003291', 'interstinal hyperperistalsis', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(375989, 'HP:0004396', 'Poor appetite', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375990, 'HP:0004396', 'Poor appetite', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375991, 'HP:0004396', 'Poor appetite', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375992, 'HP:0004396', 'Poor appetite', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375993, 'HP:0004396', 'Poor appetite', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375994, 'HP:0004396', 'Poor appetite', 'MP:0003767', 'palate inflammation', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(375995, 'HP:0004396', 'Poor appetite', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375996, 'HP:0004396', 'Poor appetite', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375997, 'HP:0004396', 'Poor appetite', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375998, 'HP:0004396', 'Poor appetite', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(375999, 'HP:0004396', 'Poor appetite', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376000, 'HP:0004396', 'Poor appetite', 'MP:0014205', 'increased intestinal epithelial sodium ion transmembrane transport', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376001, 'HP:0004396', 'Poor appetite', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376002, 'HP:0004396', 'Poor appetite', 'MP:0001873', 'stomach inflammation', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376003, 'HP:0004396', 'Poor appetite', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376004, 'HP:0004396', 'Poor appetite', 'MP:0003259', 'nausea', 0.5185185185185185, 9.977790647831666, 2.2745701186821226, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376005, 'HP:0004396', 'Poor appetite', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376006, 'HP:0004396', 'Poor appetite', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376007, 'HP:0004396', 'Poor appetite', 'MP:0010154', 'abnormal gastroesophageal sphincter physiology', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376008, 'HP:0004396', 'Poor appetite', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376009, 'HP:0004396', 'Poor appetite', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376010, 'HP:0004396', 'Poor appetite', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376011, 'HP:0004396', 'Poor appetite', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376012, 'HP:0004396', 'Poor appetite', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376013, 'HP:0004396', 'Poor appetite', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376014, 'HP:0004396', 'Poor appetite', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376015, 'HP:0004396', 'Poor appetite', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376016, 'HP:0004396', 'Poor appetite', 'MP:0031154', 'intestinal hemorrhage', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376017, 'HP:0004396', 'Poor appetite', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376018, 'HP:0004396', 'Poor appetite', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376019, 'HP:0004396', 'Poor appetite', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376020, 'HP:0004396', 'Poor appetite', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376021, 'HP:0004396', 'Poor appetite', 'MP:0008001', 'hypochlorhydria', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376022, 'HP:0004396', 'Poor appetite', 'MP:0005085', 'abnormal gallbladder physiology', 0.43333333333333335, 5.110459900932426, 1.4881305802036946, 'UPHENO:0002833', 'abnormal digestive system'),
(376023, 'HP:0004396', 'Poor appetite', 'MP:0002646', 'increased intestinal cholesterol absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376024, 'HP:0004396', 'Poor appetite', 'MP:0005342', 'abnormal intestinal lipid absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376025, 'HP:0004396', 'Poor appetite', 'MP:0001664', 'abnormal digestion', 0.5384615384615384, 9.977790647831666, 2.3178991571417833, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376026, 'HP:0004396', 'Poor appetite', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376027, 'HP:0004396', 'Poor appetite', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376028, 'HP:0004396', 'Poor appetite', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376029, 'HP:0004396', 'Poor appetite', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376030, 'HP:0004396', 'Poor appetite', 'MP:0006001', 'abnormal intestinal transit time', 0.5185185185185185, 9.977790647831666, 2.2745701186821226, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376031, 'HP:0004396', 'Poor appetite', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376032, 'HP:0004396', 'Poor appetite', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376033, 'HP:0004396', 'Poor appetite', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376034, 'HP:0004396', 'Poor appetite', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376035, 'HP:0004396', 'Poor appetite', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376036, 'HP:0004396', 'Poor appetite', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376037, 'HP:0004396', 'Poor appetite', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376038, 'HP:0004396', 'Poor appetite', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376039, 'HP:0004396', 'Poor appetite', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376040, 'HP:0004396', 'Poor appetite', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376041, 'HP:0004396', 'Poor appetite', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376042, 'HP:0004396', 'Poor appetite', 'MP:0002647', 'decreased intestinal cholesterol absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376043, 'HP:0004396', 'Poor appetite', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376044, 'HP:0004396', 'Poor appetite', 'MP:0000465', 'gastrointestinal hemorrhage', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376045, 'HP:0004396', 'Poor appetite', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376046, 'HP:0004396', 'Poor appetite', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376047, 'HP:0004396', 'Poor appetite', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376048, 'HP:0004396', 'Poor appetite', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376049, 'HP:0004396', 'Poor appetite', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376050, 'HP:0004396', 'Poor appetite', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376051, 'HP:0004396', 'Poor appetite', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376052, 'HP:0004396', 'Poor appetite', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376053, 'HP:0004396', 'Poor appetite', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376054, 'HP:0004396', 'Poor appetite', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376055, 'HP:0004396', 'Poor appetite', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376056, 'HP:0004396', 'Poor appetite', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376057, 'HP:0004396', 'Poor appetite', 'MP:0000610', 'cholestasis', 0.41935483870967744, 5.110459900932426, 1.4639317222766202, 'UPHENO:0002833', 'abnormal digestive system'),
(376058, 'HP:0004396', 'Poor appetite', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376059, 'HP:0004396', 'Poor appetite', 'MP:0014204', 'abnormal intestinal epithelial sodium ion transmembrane transport', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376060, 'HP:0004396', 'Poor appetite', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376061, 'HP:0004396', 'Poor appetite', 'MP:0008002', 'hyperchlorhydria', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376062, 'HP:0004396', 'Poor appetite', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376063, 'HP:0004396', 'Poor appetite', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376064, 'HP:0004396', 'Poor appetite', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376065, 'HP:0004396', 'Poor appetite', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376066, 'HP:0004396', 'Poor appetite', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376067, 'HP:0004396', 'Poor appetite', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376068, 'HP:0004396', 'Poor appetite', 'MP:0014206', 'decreased intestinal epithelial sodium ion transmembrane transport', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(376069, 'HP:0004396', 'Poor appetite', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376070, 'HP:0004396', 'Poor appetite', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376071, 'HP:0011518', 'Dichromacy', 'MP:0012030', 'abnormal a-wave amplitude', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376072, 'HP:0011518', 'Dichromacy', 'MP:0005253', 'abnormal eye physiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376073, 'HP:0011518', 'Dichromacy', 'MP:0008144', 'nyctalopia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376074, 'HP:0011518', 'Dichromacy', 'MP:0014179', 'abnormal blood-retina barrier function', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376075, 'HP:0011518', 'Dichromacy', 'MP:0006147', 'monocular blindness', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376076, 'HP:0011518', 'Dichromacy', 'MP:0004022', 'abnormal cone electrophysiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376077, 'HP:0011518', 'Dichromacy', 'MP:0012035', 'abnormal b-wave shape', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376078, 'HP:0011518', 'Dichromacy', 'MP:0020861', 'abnormal corneal wound healing', 0.4186046511627907, 8.795504987450572, 1.9188119493770963, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376079, 'HP:0011518', 'Dichromacy', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376080, 'HP:0011518', 'Dichromacy', 'MP:0020977', 'decreased FO-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376081, 'HP:0011518', 'Dichromacy', 'MP:0006153', 'hypermetropia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376082, 'HP:0011518', 'Dichromacy', 'MP:0012038', 'abnormal a-wave implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376083, 'HP:0011518', 'Dichromacy', 'MP:0020439', 'absent b-wave', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376084, 'HP:0011518', 'Dichromacy', 'MP:0006251', 'eyelid apraxia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376085, 'HP:0011518', 'Dichromacy', 'MP:0003011', 'delayed dark adaptation', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376086, 'HP:0011518', 'Dichromacy', 'MP:0011832', 'abnormal visual acuity', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376087, 'HP:0011518', 'Dichromacy', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376088, 'HP:0011518', 'Dichromacy', 'MP:0003100', 'myopia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376089, 'HP:0011518', 'Dichromacy', 'MP:0020963', 'decreased c-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376090, 'HP:0011518', 'Dichromacy', 'MP:0020976', 'increased FO-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376091, 'HP:0011518', 'Dichromacy', 'MP:0012032', 'abnormal ERG latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376092, 'HP:0011518', 'Dichromacy', 'MP:0020980', 'increased FO-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376093, 'HP:0011518', 'Dichromacy', 'MP:0012143', 'decreased a-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376094, 'HP:0011518', 'Dichromacy', 'MP:0012152', 'decreased a-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376095, 'HP:0011518', 'Dichromacy', 'MP:0001389', 'abnormal eye movement', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376096, 'HP:0011518', 'Dichromacy', 'MP:0006149', 'decreased visual acuity', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376097, 'HP:0011518', 'Dichromacy', 'MP:0020978', 'abnormal FO-wave implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376098, 'HP:0011518', 'Dichromacy', 'MP:0012146', 'increased b-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376099, 'HP:0011518', 'Dichromacy', 'MP:0012040', 'abnormal c-wave shape', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376100, 'HP:0011518', 'Dichromacy', 'MP:0006152', 'tunnel vision', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376101, 'HP:0011518', 'Dichromacy', 'MP:0020974', 'abnormal FO-wave shape', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376102, 'HP:0011518', 'Dichromacy', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376103, 'HP:0011518', 'Dichromacy', 'MP:0010748', 'abnormal visual evoked potential', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376104, 'HP:0011518', 'Dichromacy', 'MP:0012034', 'abnormal a-wave shape', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376105, 'HP:0011518', 'Dichromacy', 'MP:0020975', 'abnormal FO-wave amplitude', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376106, 'HP:0011518', 'Dichromacy', 'MP:0012150', 'increased b-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376107, 'HP:0011518', 'Dichromacy', 'MP:0012144', 'decreased b-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376108, 'HP:0011518', 'Dichromacy', 'MP:0002001', 'blindness', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376109, 'HP:0011518', 'Dichromacy', 'MP:0005257', 'abnormal intraocular pressure', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376110, 'HP:0011518', 'Dichromacy', 'MP:0020960', 'increased c-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376111, 'HP:0011518', 'Dichromacy', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376112, 'HP:0011518', 'Dichromacy', 'MP:0012147', 'increased a-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376113, 'HP:0011518', 'Dichromacy', 'MP:0006148', 'binocular blindness', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376114, 'HP:0011518', 'Dichromacy', 'MP:0004021', 'abnormal rod electrophysiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376115, 'HP:0011518', 'Dichromacy', 'MP:0031497', 'increased visual acuity', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376116, 'HP:0011518', 'Dichromacy', 'MP:0006150', 'double vision', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376117, 'HP:0011518', 'Dichromacy', 'MP:0014157', 'alacrima', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376118, 'HP:0011518', 'Dichromacy', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376119, 'HP:0011518', 'Dichromacy', 'MP:0012153', 'increased b-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376120, 'HP:0011518', 'Dichromacy', 'MP:0012036', 'abnormal a-wave latency', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376121, 'HP:0011518', 'Dichromacy', 'MP:0012151', 'increased a-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376122, 'HP:0011518', 'Dichromacy', 'MP:0020860', 'abnormal cornea physiology', 0.46153846153846156, 8.795504987450572, 2.014811117787919, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376123, 'HP:0011518', 'Dichromacy', 'MP:0020959', 'decreased c-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376124, 'HP:0011518', 'Dichromacy', 'MP:0012033', 'abnormal ERG implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376125, 'HP:0011518', 'Dichromacy', 'MP:0013468', 'chromodacryorrhea', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376126, 'HP:0011518', 'Dichromacy', 'MP:0005260', 'ocular hypotension', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376127, 'HP:0011518', 'Dichromacy', 'MP:0006145', 'legal blindness', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376128, 'HP:0011518', 'Dichromacy', 'MP:0005258', 'ocular hypertension', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376129, 'HP:0011518', 'Dichromacy', 'MP:0008145', 'hemeralopia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376130, 'HP:0011518', 'Dichromacy', 'MP:0012145', 'increased a-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376131, 'HP:0011518', 'Dichromacy', 'MP:0012148', 'decreased a-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376132, 'HP:0011518', 'Dichromacy', 'MP:0020962', 'increased c-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376133, 'HP:0011518', 'Dichromacy', 'MP:0012039', 'abnormal b-wave implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376134, 'HP:0011518', 'Dichromacy', 'MP:0001337', 'dry eyes', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376135, 'HP:0011518', 'Dichromacy', 'MP:0002090', 'abnormal vision', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376136, 'HP:0011518', 'Dichromacy', 'MP:0020219', 'increased tear production', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376137, 'HP:0011518', 'Dichromacy', 'MP:0020218', 'abnormal tear production', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376138, 'HP:0011518', 'Dichromacy', 'MP:0005551', 'abnormal eye electrophysiology', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376139, 'HP:0011518', 'Dichromacy', 'MP:0003096', 'increased corneal light-scattering', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376140, 'HP:0011518', 'Dichromacy', 'MP:0020958', 'abnormal c-wave implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376141, 'HP:0011518', 'Dichromacy', 'MP:0012037', 'abnormal b-wave latency', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376142, 'HP:0011518', 'Dichromacy', 'MP:0006190', 'retina ischemia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376143, 'HP:0011518', 'Dichromacy', 'MP:0012154', 'decreased b-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376144, 'HP:0011518', 'Dichromacy', 'MP:0001999', 'photosensitivity', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376145, 'HP:0011518', 'Dichromacy', 'MP:0020979', 'decreased FO-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376146, 'HP:0011518', 'Dichromacy', 'MP:0010749', 'absent visual evoked potential', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376147, 'HP:0011518', 'Dichromacy', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376148, 'HP:0011518', 'Dichromacy', 'MP:0013145', 'eye discharge', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376149, 'HP:0011518', 'Dichromacy', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376150, 'HP:0011518', 'Dichromacy', 'MP:0020220', 'decreased tear production', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376151, 'HP:0011518', 'Dichromacy', 'MP:0014132', 'abnormal tear film physiology', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376152, 'HP:0011518', 'Dichromacy', 'MP:0003101', 'high myopia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376153, 'HP:0011518', 'Dichromacy', 'MP:0012149', 'decreased b-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376154, 'HP:0011518', 'Dichromacy', 'MP:0012031', 'abnormal b-wave amplitude', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376155, 'HP:0011518', 'Dichromacy', 'MP:0020961', 'abnormal c-wave amplitude', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(376156, 'HP:0100875', 'Hemimacroglossia', 'MP:0009906', 'increased tongue size', 0.43283582089552236, 15.607147267911275, 2.599102229529205, 'UPHENO:0001398', 'increased size of the tongue'),
(376157, 'HP:0010292', 'Absent uvula', 'MP:0013766', 'absent palatal rugae', 0.4024390243902439, 12.147715649273977, 2.2110438336821634, 'UPHENO:0025923', 'absent anatomical entity in the midface'),
(376158, 'HP:0010292', 'Absent uvula', 'MP:0009894', 'absent hard palate', 0.4342105263157895, 12.147715649273977, 2.296664103783095, 'UPHENO:0025923', 'absent anatomical entity in the midface'),
(376159, 'HP:0010292', 'Absent uvula', 'MP:0030290', 'absent soft palate', 0.4533333333333333, 12.519684426660936, 2.3823497378469902, 'UPHENO:0088088', 'abnormal soft palate morphology'),
(376160, 'HP:0025700', 'Anhydramnios', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376161, 'HP:0025700', 'Anhydramnios', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376162, 'HP:0025700', 'Anhydramnios', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376163, 'HP:0025700', 'Anhydramnios', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376164, 'HP:0025700', 'Anhydramnios', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376165, 'HP:0025700', 'Anhydramnios', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376166, 'HP:0025700', 'Anhydramnios', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376167, 'HP:0025700', 'Anhydramnios', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376168, 'HP:0025700', 'Anhydramnios', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376169, 'HP:0025700', 'Anhydramnios', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376170, 'HP:0025700', 'Anhydramnios', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376171, 'HP:0025700', 'Anhydramnios', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376172, 'HP:0025700', 'Anhydramnios', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376173, 'HP:0025700', 'Anhydramnios', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376174, 'HP:0025700', 'Anhydramnios', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376175, 'HP:0025700', 'Anhydramnios', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376176, 'HP:0025700', 'Anhydramnios', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376177, 'HP:0025700', 'Anhydramnios', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376178, 'HP:0025700', 'Anhydramnios', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376179, 'HP:0025700', 'Anhydramnios', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376180, 'HP:0025700', 'Anhydramnios', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376181, 'HP:0025700', 'Anhydramnios', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376182, 'HP:0025700', 'Anhydramnios', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376183, 'HP:0025700', 'Anhydramnios', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376184, 'HP:0025700', 'Anhydramnios', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376185, 'HP:0025700', 'Anhydramnios', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376186, 'HP:0025700', 'Anhydramnios', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376187, 'HP:0025700', 'Anhydramnios', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376188, 'HP:0025700', 'Anhydramnios', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376189, 'HP:0025700', 'Anhydramnios', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376190, 'HP:0025700', 'Anhydramnios', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376191, 'HP:0025700', 'Anhydramnios', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376192, 'HP:0025700', 'Anhydramnios', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376193, 'HP:0025700', 'Anhydramnios', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376194, 'HP:0025700', 'Anhydramnios', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376195, 'HP:0025700', 'Anhydramnios', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376196, 'HP:0025700', 'Anhydramnios', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376197, 'HP:0025700', 'Anhydramnios', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376198, 'HP:0000873', 'Diabetes insipidus', 'MP:0011488', 'abnormal ureterovesical junction morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376199, 'HP:0000873', 'Diabetes insipidus', 'MP:0004179', 'transmission ratio distortion', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376200, 'HP:0000873', 'Diabetes insipidus', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376201, 'HP:0000873', 'Diabetes insipidus', 'MP:0001156', 'abnormal spermatogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376202, 'HP:0000873', 'Diabetes insipidus', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376203, 'HP:0000873', 'Diabetes insipidus', 'MP:0002971', 'abnormal brown adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376204, 'HP:0000873', 'Diabetes insipidus', 'MP:0013119', 'abdomen swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376205, 'HP:0000873', 'Diabetes insipidus', 'MP:0000003', 'abnormal adipose tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376206, 'HP:0000873', 'Diabetes insipidus', 'MP:0000736', 'delayed muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376207, 'HP:0000873', 'Diabetes insipidus', 'MP:0013123', 'head/neck swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376208, 'HP:0000873', 'Diabetes insipidus', 'MP:0002399', 'abnormal pluripotent precursor cell morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376209, 'HP:0000873', 'Diabetes insipidus', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376210, 'HP:0000873', 'Diabetes insipidus', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376211, 'HP:0000873', 'Diabetes insipidus', 'MP:0000428', 'abnormal craniofacial morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376212, 'HP:0000873', 'Diabetes insipidus', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376213, 'HP:0000873', 'Diabetes insipidus', 'MP:0012058', 'abnormal morula morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376214, 'HP:0000873', 'Diabetes insipidus', 'MP:0014066', 'Rosenthal fibers', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376215, 'HP:0000873', 'Diabetes insipidus', 'MP:0003385', 'abnormal body wall morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376216, 'HP:0000873', 'Diabetes insipidus', 'MP:0020981', 'abnormal immune system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376217, 'HP:0000873', 'Diabetes insipidus', 'MP:0002133', 'abnormal respiratory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376218, 'HP:0000873', 'Diabetes insipidus', 'MP:0001890', 'anencephaly', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376219, 'HP:0000873', 'Diabetes insipidus', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376220, 'HP:0000873', 'Diabetes insipidus', 'MP:0014063', 'Lafora bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376221, 'HP:0000873', 'Diabetes insipidus', 'MP:0008493', 'alpha-synuclein inclusion body', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376222, 'HP:0000873', 'Diabetes insipidus', 'MP:0004996', 'abnormal CNS synapse formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376223, 'HP:0000873', 'Diabetes insipidus', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376224, 'HP:0000873', 'Diabetes insipidus', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376225, 'HP:0000873', 'Diabetes insipidus', 'MP:0013118', 'swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376226, 'HP:0000873', 'Diabetes insipidus', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376227, 'HP:0000873', 'Diabetes insipidus', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376228, 'HP:0000873', 'Diabetes insipidus', 'MP:0010435', 'abnormal heart atrium and ventricle connection', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376229, 'HP:0000873', 'Diabetes insipidus', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376230, 'HP:0000873', 'Diabetes insipidus', 'MP:0020973', 'abnormal gland development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376231, 'HP:0000873', 'Diabetes insipidus', 'MP:0003384', 'abnormal ventral body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376232, 'HP:0000873', 'Diabetes insipidus', 'MP:0010233', 'hairless tail', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376233, 'HP:0000873', 'Diabetes insipidus', 'MP:0003942', 'abnormal urinary system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376234, 'HP:0000873', 'Diabetes insipidus', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376235, 'HP:0000873', 'Diabetes insipidus', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376236, 'HP:0000873', 'Diabetes insipidus', 'MP:0013304', 'osteophytes', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376237, 'HP:0000873', 'Diabetes insipidus', 'MP:0003115', 'abnormal respiratory system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376238, 'HP:0000873', 'Diabetes insipidus', 'MP:0000467', 'abnormal esophagus morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376239, 'HP:0000873', 'Diabetes insipidus', 'MP:0001663', 'abnormal digestive system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376240, 'HP:0000873', 'Diabetes insipidus', 'MP:0000733', 'abnormal muscle development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376241, 'HP:0000873', 'Diabetes insipidus', 'MP:0005360', 'urolithiasis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376242, 'HP:0000873', 'Diabetes insipidus', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376243, 'HP:0000873', 'Diabetes insipidus', 'MP:0001790', 'abnormal immune system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376244, 'HP:0000873', 'Diabetes insipidus', 'MP:0014134', 'abnormal embryo morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376245, 'HP:0000873', 'Diabetes insipidus', 'MP:0031100', 'hemoptysis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376246, 'HP:0000873', 'Diabetes insipidus', 'MP:0013133', 'pale limbs', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376247, 'HP:0000873', 'Diabetes insipidus', 'MP:0013124', 'mouth swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376248, 'HP:0000873', 'Diabetes insipidus', 'MP:0013561', 'abnormal endocrine gland physiology', 0.43478260869565216, 6.358033815197547, 1.6626372209074232, 'UPHENO:0003116', 'abnormal endocrine system'),
(376249, 'HP:0000873', 'Diabetes insipidus', 'MP:0003633', 'abnormal nervous system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376250, 'HP:0000873', 'Diabetes insipidus', 'MP:0014062', 'nervous system inclusion bodies', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376251, 'HP:0000873', 'Diabetes insipidus', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376252, 'HP:0000873', 'Diabetes insipidus', 'MP:0008923', 'thoracoschisis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376253, 'HP:0000873', 'Diabetes insipidus', 'MP:0002211', 'abnormal primary sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376254, 'HP:0000873', 'Diabetes insipidus', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376255, 'HP:0000873', 'Diabetes insipidus', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376256, 'HP:0000873', 'Diabetes insipidus', 'MP:0031092', 'dysgeusia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376257, 'HP:0000873', 'Diabetes insipidus', 'MP:0001725', 'abnormal umbilical cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376258, 'HP:0000873', 'Diabetes insipidus', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376259, 'HP:0000873', 'Diabetes insipidus', 'MP:0003861', 'abnormal nervous system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376260, 'HP:0000873', 'Diabetes insipidus', 'MP:0001533', 'abnormal skeleton physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376261, 'HP:0000873', 'Diabetes insipidus', 'MP:0011174', 'lipodystrophy', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376262, 'HP:0000873', 'Diabetes insipidus', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376263, 'HP:0000873', 'Diabetes insipidus', 'MP:0004558', 'delayed allantois development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376264, 'HP:0000873', 'Diabetes insipidus', 'MP:0031348', 'bone fibrous dysplasia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376265, 'HP:0000873', 'Diabetes insipidus', 'MP:0013083', 'tail wound', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376266, 'HP:0000873', 'Diabetes insipidus', 'MP:0001175', 'abnormal lung morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376267, 'HP:0000873', 'Diabetes insipidus', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376268, 'HP:0000873', 'Diabetes insipidus', 'MP:0001726', 'abnormal allantois morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376269, 'HP:0000873', 'Diabetes insipidus', 'MP:0013113', 'greasy tail', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376270, 'HP:0000873', 'Diabetes insipidus', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376271, 'HP:0000873', 'Diabetes insipidus', 'MP:0000752', 'dystrophic muscle', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376272, 'HP:0000873', 'Diabetes insipidus', 'MP:0002132', 'abnormal respiratory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376273, 'HP:0000873', 'Diabetes insipidus', 'MP:0006280', 'abnormal digit development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376274, 'HP:0000873', 'Diabetes insipidus', 'MP:0000566', 'synostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376275, 'HP:0000873', 'Diabetes insipidus', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376276, 'HP:0000873', 'Diabetes insipidus', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376277, 'HP:0000873', 'Diabetes insipidus', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376278, 'HP:0000873', 'Diabetes insipidus', 'MP:0002932', 'abnormal joint morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376279, 'HP:0000873', 'Diabetes insipidus', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376280, 'HP:0000873', 'Diabetes insipidus', 'MP:0005334', 'abnormal fat pad morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376281, 'HP:0000873', 'Diabetes insipidus', 'MP:0000767', 'abnormal smooth muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376282, 'HP:0000873', 'Diabetes insipidus', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376283, 'HP:0000873', 'Diabetes insipidus', 'MP:0003301', 'peptic ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376284, 'HP:0000873', 'Diabetes insipidus', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376285, 'HP:0000873', 'Diabetes insipidus', 'MP:0011487', 'abnormal ureteropelvic junction morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376286, 'HP:0000873', 'Diabetes insipidus', 'MP:0012260', 'encephalomeningocele', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376287, 'HP:0000873', 'Diabetes insipidus', 'MP:0013332', 'peliosis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376288, 'HP:0000873', 'Diabetes insipidus', 'MP:0000731', 'increased collagen deposition in the muscles', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376289, 'HP:0000873', 'Diabetes insipidus', 'MP:0031377', 'ambiguous external genitalia', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376290, 'HP:0000873', 'Diabetes insipidus', 'MP:0005499', 'abnormal olfactory system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376291, 'HP:0000873', 'Diabetes insipidus', 'MP:0002113', 'abnormal skeleton development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376292, 'HP:0000873', 'Diabetes insipidus', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376293, 'HP:0000873', 'Diabetes insipidus', 'MP:0005508', 'abnormal skeleton morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376294, 'HP:0000873', 'Diabetes insipidus', 'MP:0014067', 'Hirano bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376295, 'HP:0000873', 'Diabetes insipidus', 'MP:0013120', 'urogenital swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376296, 'HP:0000873', 'Diabetes insipidus', 'MP:0030222', 'hyperostosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376297, 'HP:0000873', 'Diabetes insipidus', 'MP:0014065', 'Lewy bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376298, 'HP:0000873', 'Diabetes insipidus', 'MP:0000358', 'abnormal cell morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376299, 'HP:0000873', 'Diabetes insipidus', 'MP:0000427', 'abnormal hair cycle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376300, 'HP:0000873', 'Diabetes insipidus', 'MP:0013177', 'abnormal tail tip morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376301, 'HP:0000873', 'Diabetes insipidus', 'MP:0005459', 'decreased percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376302, 'HP:0000873', 'Diabetes insipidus', 'MP:0003119', 'abnormal digestive system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376303, 'HP:0000873', 'Diabetes insipidus', 'MP:0020982', 'abnormal skin adnexa development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376304, 'HP:0000873', 'Diabetes insipidus', 'MP:0002060', 'abnormal skin morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376305, 'HP:0000873', 'Diabetes insipidus', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376306, 'HP:0000873', 'Diabetes insipidus', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376307, 'HP:0000873', 'Diabetes insipidus', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376308, 'HP:0000873', 'Diabetes insipidus', 'MP:0005500', 'abnormal gustatory system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376309, 'HP:0000873', 'Diabetes insipidus', 'MP:0013126', 'teat swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376310, 'HP:0000873', 'Diabetes insipidus', 'MP:0001986', 'abnormal taste sensitivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376311, 'HP:0000873', 'Diabetes insipidus', 'MP:0012531', 'delayed limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376312, 'HP:0000873', 'Diabetes insipidus', 'MP:0010478', 'intracranial aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376313, 'HP:0000873', 'Diabetes insipidus', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376314, 'HP:0000873', 'Diabetes insipidus', 'MP:0000462', 'abnormal digestive system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376315, 'HP:0000873', 'Diabetes insipidus', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376316, 'HP:0000873', 'Diabetes insipidus', 'MP:0005029', 'abnormal amnion morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376317, 'HP:0000873', 'Diabetes insipidus', 'MP:0005458', 'increased percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376318, 'HP:0000873', 'Diabetes insipidus', 'MP:0002653', 'abnormal ependyma morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376319, 'HP:0000873', 'Diabetes insipidus', 'MP:0002108', 'abnormal muscle morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376320, 'HP:0000873', 'Diabetes insipidus', 'MP:0012685', 'abnormal primitive streak elongation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376321, 'HP:0000873', 'Diabetes insipidus', 'MP:0002111', 'abnormal tail morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376322, 'HP:0000873', 'Diabetes insipidus', 'MP:0003705', 'abnormal hypodermis morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376323, 'HP:0000873', 'Diabetes insipidus', 'MP:0013558', 'abnormal exocrine gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376324, 'HP:0000873', 'Diabetes insipidus', 'MP:0020370', 'abnormal glymphatic system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376325, 'HP:0000873', 'Diabetes insipidus', 'MP:0005457', 'abnormal percent body fat/body weight', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376326, 'HP:0000873', 'Diabetes insipidus', 'MP:0002160', 'abnormal reproductive system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376327, 'HP:0000873', 'Diabetes insipidus', 'MP:0031277', 'pectus carinatum', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376328, 'HP:0000873', 'Diabetes insipidus', 'MP:0003300', 'gastrointestinal ulcer', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376329, 'HP:0000873', 'Diabetes insipidus', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376330, 'HP:0000873', 'Diabetes insipidus', 'MP:0012514', 'pectus excavatum', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376331, 'HP:0000873', 'Diabetes insipidus', 'MP:0002114', 'abnormal axial skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376332, 'HP:0000873', 'Diabetes insipidus', 'MP:0002109', 'abnormal limb morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376333, 'HP:0000873', 'Diabetes insipidus', 'MP:0014064', 'argyrophilic inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376334, 'HP:0000873', 'Diabetes insipidus', 'MP:0012684', 'abnormal pleural cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376335, 'HP:0000873', 'Diabetes insipidus', 'MP:0011167', 'abnormal adipose tissue development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376336, 'HP:0000873', 'Diabetes insipidus', 'MP:0000550', 'abnormal forelimb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376337, 'HP:0000873', 'Diabetes insipidus', 'MP:0010942', 'abnormal respiratory epithelium morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376338, 'HP:0000873', 'Diabetes insipidus', 'MP:0003795', 'abnormal bone structure', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376339, 'HP:0000873', 'Diabetes insipidus', 'MP:0010874', 'abnormal bone volume', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376340, 'HP:0000873', 'Diabetes insipidus', 'MP:0020516', 'abnormal visceral yolk sac mesenchyme morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376341, 'HP:0000873', 'Diabetes insipidus', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376342, 'HP:0000873', 'Diabetes insipidus', 'MP:0001929', 'abnormal gametogenesis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376343, 'HP:0000873', 'Diabetes insipidus', 'MP:0002837', 'dystrophic cardiac calcinosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376344, 'HP:0000873', 'Diabetes insipidus', 'MP:0001944', 'abnormal pancreas morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376345, 'HP:0000873', 'Diabetes insipidus', 'MP:0001919', 'abnormal reproductive system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376346, 'HP:0000873', 'Diabetes insipidus', 'MP:0013283', 'failure of ventral body wall closure', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376347, 'HP:0000873', 'Diabetes insipidus', 'MP:0005504', 'abnormal ligament morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376348, 'HP:0000873', 'Diabetes insipidus', 'MP:0002836', 'abnormal chorion morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376349, 'HP:0000873', 'Diabetes insipidus', 'MP:0002970', 'abnormal white adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376350, 'HP:0000873', 'Diabetes insipidus', 'MP:0013560', 'abnormal endocrine gland morphology', 0.45454545454545453, 6.358033815197547, 1.7000045207423242, 'UPHENO:0003116', 'abnormal endocrine system'),
(376351, 'HP:0000873', 'Diabetes insipidus', 'MP:0001984', 'abnormal olfaction', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376352, 'HP:0000873', 'Diabetes insipidus', 'MP:0006279', 'abnormal limb development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376353, 'HP:0000873', 'Diabetes insipidus', 'MP:0004957', 'abnormal blastocyst morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376354, 'HP:0000873', 'Diabetes insipidus', 'MP:0003632', 'abnormal nervous system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376355, 'HP:0000873', 'Diabetes insipidus', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376356, 'HP:0000873', 'Diabetes insipidus', 'MP:0005652', 'sex reversal', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376357, 'HP:0000873', 'Diabetes insipidus', 'MP:0013122', 'tail swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376358, 'HP:0000873', 'Diabetes insipidus', 'MP:0003279', 'aneurysm', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376359, 'HP:0000873', 'Diabetes insipidus', 'MP:0010352', 'gastrointestinal tract polyps', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376360, 'HP:0000873', 'Diabetes insipidus', 'MP:0010678', 'abnormal skin adnexa morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376361, 'HP:0000873', 'Diabetes insipidus', 'MP:0005621', 'abnormal cell physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376362, 'HP:0000873', 'Diabetes insipidus', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376363, 'HP:0000873', 'Diabetes insipidus', 'MP:0002106', 'abnormal muscle physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376364, 'HP:0000873', 'Diabetes insipidus', 'MP:0020452', 'abnormal axon radial sorting', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376365, 'HP:0000873', 'Diabetes insipidus', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376366, 'HP:0000873', 'Diabetes insipidus', 'MP:0000572', 'abnormal autopod morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376367, 'HP:0000873', 'Diabetes insipidus', 'MP:0013121', 'testicular swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376368, 'HP:0000873', 'Diabetes insipidus', 'MP:0004557', 'dilated allantois', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376369, 'HP:0000873', 'Diabetes insipidus', 'MP:0002212', 'abnormal secondary sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376370, 'HP:0000873', 'Diabetes insipidus', 'MP:0003935', 'abnormal craniofacial development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376371, 'HP:0000873', 'Diabetes insipidus', 'MP:0010122', 'abnormal bone mineral content', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376372, 'HP:0000873', 'Diabetes insipidus', 'MP:0002163', 'abnormal gland morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376373, 'HP:0000873', 'Diabetes insipidus', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376374, 'HP:0000873', 'Diabetes insipidus', 'MP:0003936', 'abnormal reproductive system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376375, 'HP:0000873', 'Diabetes insipidus', 'MP:0005422', 'osteosclerosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376376, 'HP:0000873', 'Diabetes insipidus', 'MP:0000685', 'abnormal immune system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376377, 'HP:0000873', 'Diabetes insipidus', 'MP:0000556', 'abnormal hindlimb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376378, 'HP:0000873', 'Diabetes insipidus', 'MP:0020515', 'abnormal visceral yolk sac endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376379, 'HP:0000873', 'Diabetes insipidus', 'MP:0013125', 'thorax swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376380, 'HP:0000873', 'Diabetes insipidus', 'MP:0031099', 'abnormal sputum morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376381, 'HP:0000873', 'Diabetes insipidus', 'MP:0010425', 'abnormal heart and great vessel attachment', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376382, 'HP:0000873', 'Diabetes insipidus', 'MP:0010820', 'abnormal pleura morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376383, 'HP:0000873', 'Diabetes insipidus', 'MP:0004134', 'abnormal chest morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376384, 'HP:0000873', 'Diabetes insipidus', 'MP:0002210', 'abnormal sex determination', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376385, 'HP:0000873', 'Diabetes insipidus', 'MP:0006281', 'abnormal tail development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376386, 'HP:0000873', 'Diabetes insipidus', 'MP:0031310', 'abnormal cyst', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376387, 'HP:0000873', 'Diabetes insipidus', 'MP:0002184', 'abnormal innervation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376388, 'HP:0000873', 'Diabetes insipidus', 'MP:0002925', 'abnormal cardiovascular development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376389, 'HP:0000873', 'Diabetes insipidus', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376390, 'HP:0000873', 'Diabetes insipidus', 'MP:0001722', 'pale yolk sac', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376391, 'HP:0000873', 'Diabetes insipidus', 'MP:0009877', 'exostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376392, 'HP:0000873', 'Diabetes insipidus', 'MP:0000266', 'abnormal heart morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376393, 'HP:0000873', 'Diabetes insipidus', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(376394, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0000063', 'decreased bone mineral density', 0.42857142857142855, 10.340360727216375, 2.105132577489365, 'UPHENO:0084654', 'abnormal bone element mass density'),
(376395, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0020010', 'decreased bone mineral density of femur', 0.40540540540540543, 10.340360727216375, 2.0474467349983216, 'UPHENO:0084654', 'abnormal bone element mass density'),
(376396, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0021187', 'increased bone mineral density of vertebrae', 0.4146341463414634, 10.692263881549227, 2.1055587636026276, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(376397, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0000062', 'increased bone mineral density', 0.5151515151515151, 10.692263881549227, 2.346941826927098, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(376398, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0020011', 'increased bone mineral density of femur', 0.4857142857142857, 10.692263881549227, 2.2789000227950633, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(376399, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0013615', 'increased volumetric bone mineral density', 0.4857142857142857, 10.692263881549227, 2.2789000227950633, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(376400, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0010119', 'abnormal bone mineral density', 0.46875, 10.340360727216375, 2.201600347674999, 'UPHENO:0084654', 'abnormal bone element mass density'),
(376401, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0013617', 'increased areal bone mineral density', 0.4857142857142857, 10.692263881549227, 2.2789000227950633, 'UPHENO:0084450', 'abnormally increased bone element mass density'),
(376402, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0013618', 'decreased areal bone mineral density', 0.40540540540540543, 10.340360727216375, 2.0474467349983216, 'UPHENO:0084654', 'abnormal bone element mass density'),
(376403, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0013614', 'abnormal areal bone mineral density', 0.45454545454545453, 10.340360727216375, 2.1679861546874633, 'UPHENO:0084654', 'abnormal bone element mass density'),
(376404, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0013616', 'decreased volumetric bone mineral density', 0.40540540540540543, 10.340360727216375, 2.0474467349983216, 'UPHENO:0084654', 'abnormal bone element mass density'),
(376405, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0020009', 'abnormal bone mineral density of femur', 0.45454545454545453, 10.340360727216375, 2.1679861546874633, 'UPHENO:0084654', 'abnormal bone element mass density'),
(376406, 'HP:0100925', 'Sclerosis of foot bone', 'MP:0013613', 'abnormal volumetric bone mineral density', 0.45454545454545453, 10.340360727216375, 2.1679861546874633, 'UPHENO:0084654', 'abnormal bone element mass density'),
(376407, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0002691', 'small stomach', 0.425531914893617, 10.592196926445304, 2.1230444745790313, 'UPHENO:0081609', 'abnormal stomach morphology'),
(376408, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0010785', 'abnormal stomach pyloric region morphology', 0.4186046511627907, 13.944182255188847, 2.416009012541904, 'UPHENO:0086960', 'abnormal pylorus morphology'),
(376409, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0005210', 'disorganized stomach mucosa', 0.40816326530612246, 10.592196926445304, 2.079265659857679, 'UPHENO:0081609', 'abnormal stomach morphology'),
(376410, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0003272', 'duodenal atresia', 0.4166666666666667, 11.397693902282326, 2.1792290209959506, 'UPHENO:0063565', 'anatomical entity atresia'),
(376411, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0014159', 'stomach fibrosis', 0.4444444444444444, 10.592196926445304, 2.1697103674039386, 'UPHENO:0081609', 'abnormal stomach morphology'),
(376412, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0031343', 'colon atresia', 0.425531914893617, 11.397693902282326, 2.202290287770779, 'UPHENO:0063565', 'anatomical entity atresia'),
(376413, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0011878', 'jejunum atresia', 0.4166666666666667, 11.397693902282326, 2.1792290209959506, 'UPHENO:0063565', 'anatomical entity atresia'),
(376414, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0003130', 'anal atresia', 0.425531914893617, 11.397693902282326, 2.202290287770779, 'UPHENO:0063565', 'anatomical entity atresia'),
(376415, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0003883', 'enlarged stomach', 0.425531914893617, 10.592196926445304, 2.1230444745790313, 'UPHENO:0081609', 'abnormal stomach morphology'),
(376416, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0011879', 'ileum atresia', 0.40816326530612246, 11.397693902282326, 2.156877363253469, 'UPHENO:0063565', 'anatomical entity atresia'),
(376417, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0009511', 'distended stomach', 0.4166666666666667, 10.592196926445304, 2.1008130297622576, 'UPHENO:0081609', 'abnormal stomach morphology'),
(376418, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0013576', 'small forestomach', 0.40816326530612246, 10.592196926445304, 2.079265659857679, 'UPHENO:0081609', 'abnormal stomach morphology'),
(376419, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0009510', 'cecal atresia', 0.40816326530612246, 11.397693902282326, 2.156877363253469, 'UPHENO:0063565', 'anatomical entity atresia'),
(376420, 'HP:0004399', 'Congenital pyloric atresia', 'MP:0011748', 'intestinal fibrosis', 0.4090909090909091, 9.04745152580055, 1.9238581469655396, 'UPHENO:0084771', 'abnormal anatomical entity morphology in the alimentary part of gastrointestinal system'),
(376421, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012619', 'increased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376422, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376423, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376424, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376425, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031077', 'increased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376426, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011894', 'decreased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376427, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376428, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0009699', 'hyperchylomicronemia', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376429, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011885', 'abnormal circulating lipase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376430, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376431, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376432, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0005416', 'abnormal circulating protein level', 0.4444444444444444, 8.144985856518405, 1.9026281071213522, 'UPHENO:0046362', 'abnormal protein level'),
(376433, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011887', 'decreased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376434, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031081', 'abnormal circulating D-dimer level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376435, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376436, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031065', 'increased circulating procalcitonin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376437, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012618', 'decreased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376438, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012328', 'decreased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376439, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031082', 'decreased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376440, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0004730', 'abnormal circulating gastrin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376441, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031107', 'abnormal circulating myoglobin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376442, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011890', 'increased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376443, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376444, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0013256', 'increased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376445, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376446, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376447, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376448, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376449, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0002695', 'abnormal circulating glucagon level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376450, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012326', 'increased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376451, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376452, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376453, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011888', 'abnormal circulating total protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376454, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012616', 'increased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376455, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012223', 'increased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376456, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376457, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0001560', 'abnormal circulating insulin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376458, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011912', 'abnormal circulating fibronectin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376459, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376460, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020258', 'decreased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376461, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376462, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376463, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0008820', 'abnormal blood uric acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(376464, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012666', 'increased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376465, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012615', 'decreased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376466, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376467, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031075', 'abnormal circulating troponin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376468, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012329', 'increased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376469, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376470, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011886', 'increased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376471, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020984', 'decreased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376472, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031079', 'increased circulating troponin I level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376473, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0005419', 'decreased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376474, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376475, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012327', 'abnormal circulating factor VIII level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376476, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020246', 'abnormal circulating arginase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376477, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031078', 'increased circulating troponin T level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376478, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0008805', 'decreased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376479, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011891', 'decreased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376480, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012325', 'decreased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376481, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020256', 'abnormal circulating factor XII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376482, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0013257', 'decreased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376483, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012622', 'increased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376484, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012222', 'decreased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376485, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012332', 'decreased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376486, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0008804', 'abnormal circulating amylase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376487, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376488, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376489, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012617', 'abnormal circulating factor X level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376490, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031076', 'decreased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376491, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376492, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376493, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0008806', 'increased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376494, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011892', 'abnormal circulating transferrin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376495, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020255', 'absent circulating factor XII protein', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376496, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012621', 'decreased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376497, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376498, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020983', 'abnormal circulating factor XI level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376499, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031108', 'increased circulating myoglobin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376500, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376501, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020248', 'decreased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376502, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(376503, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376504, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012221', 'abnormal circulating prothrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376505, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011889', 'abnormal circulating ferritin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376506, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376507, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012324', 'abnormal circulating antithrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376508, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0013255', 'abnormal circulating thrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376509, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376510, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011893', 'increased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376511, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0001570', 'abnormal circulating enzyme level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376512, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031083', 'increased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376513, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376514, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0002941', 'increased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376515, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020257', 'increased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376516, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012333', 'increased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376517, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376518, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376519, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0005667', 'abnormal circulating leptin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376520, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0002965', 'increased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376521, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376522, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(376523, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(376524, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020985', 'increased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376525, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0012614', 'abnormal circulating factor IX level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(376526, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376527, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0003349', 'abnormal circulating renin level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376528, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376529, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4074074074074074, 8.670509328908704, 1.8794759180666387, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(376530, 'HP:0040240', 'Increased ratio of VWF propeptide to VWF antigen', 'MP:0020247', 'increased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(376531, 'HP:0031525', 'Keratoacanthoma', 'MP:0003717', 'pallor', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376532, 'HP:0031525', 'Keratoacanthoma', 'MP:0008854', 'bleb', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376533, 'HP:0031525', 'Keratoacanthoma', 'MP:0008816', 'petechiae', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376534, 'HP:0031525', 'Keratoacanthoma', 'MP:0011515', 'purpura', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376535, 'HP:0031525', 'Keratoacanthoma', 'MP:0001201', 'translucent skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376536, 'HP:0031525', 'Keratoacanthoma', 'MP:0005275', 'abnormal skin tensile strength', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376537, 'HP:0031525', 'Keratoacanthoma', 'MP:0001193', 'psoriasis', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376538, 'HP:0031525', 'Keratoacanthoma', 'MP:0001216', 'abnormal epidermal layer morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376539, 'HP:0031525', 'Keratoacanthoma', 'MP:0001191', 'abnormal skin condition', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(376540, 'HP:0031525', 'Keratoacanthoma', 'MP:0031103', 'skin rash', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376541, 'HP:0031525', 'Keratoacanthoma', 'MP:0001192', 'scaly skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376542, 'HP:0031525', 'Keratoacanthoma', 'MP:0009563', 'dyskeratosis', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(376543, 'HP:0031525', 'Keratoacanthoma', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376544, 'HP:0031525', 'Keratoacanthoma', 'MP:0009441', 'delayed skin barrier formation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376545, 'HP:0031525', 'Keratoacanthoma', 'MP:0003652', 'abnormal skin turgor', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376546, 'HP:0031525', 'Keratoacanthoma', 'MP:0001208', 'blistering', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376547, 'HP:0031525', 'Keratoacanthoma', 'MP:0001195', 'flaky skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376548, 'HP:0031525', 'Keratoacanthoma', 'MP:0005421', 'loose skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376549, 'HP:0031525', 'Keratoacanthoma', 'MP:0009931', 'abnormal skin appearance', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(376550, 'HP:0031525', 'Keratoacanthoma', 'MP:0008856', 'fetal bleb', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376551, 'HP:0031525', 'Keratoacanthoma', 'MP:0001196', 'shiny skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376552, 'HP:0031525', 'Keratoacanthoma', 'MP:0011239', 'abnormal skin coloration', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(376553, 'HP:0031525', 'Keratoacanthoma', 'MP:0001243', 'abnormal dermal layer morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376554, 'HP:0031525', 'Keratoacanthoma', 'MP:0001213', 'abnormal skin cell number', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376555, 'HP:0031525', 'Keratoacanthoma', 'MP:0005501', 'abnormal skin physiology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(376556, 'HP:0031525', 'Keratoacanthoma', 'MP:0002897', 'blotchy skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376557, 'HP:0031525', 'Keratoacanthoma', 'MP:0001212', 'skin lesions', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376558, 'HP:0031525', 'Keratoacanthoma', 'MP:0009827', 'skin detachment', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376559, 'HP:0031525', 'Keratoacanthoma', 'MP:0001210', 'skin ridges', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376560, 'HP:0031525', 'Keratoacanthoma', 'MP:0010071', 'abnormal pruritus', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376561, 'HP:0031525', 'Keratoacanthoma', 'MP:0002060', 'abnormal skin morphology', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(376562, 'HP:0031525', 'Keratoacanthoma', 'MP:0009473', 'abnormal skin exfoliation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376563, 'HP:0031525', 'Keratoacanthoma', 'MP:0003941', 'abnormal skin development', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(376564, 'HP:0031525', 'Keratoacanthoma', 'MP:0003853', 'dry skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376565, 'HP:0031525', 'Keratoacanthoma', 'MP:0001198', 'tight skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376566, 'HP:0031525', 'Keratoacanthoma', 'MP:0012078', 'abnormal tail ring morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(376567, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0003881', 'abnormal nephron morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376568, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011382', 'abnormal kidney lobule morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376569, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011402', 'renal cast', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376570, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376571, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376572, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376573, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011383', 'abnormal kidney capsule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376574, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376575, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0004195', 'abnormal kidney calyx morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376576, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376577, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376578, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0009860', 'nephrosclerosis', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376579, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376580, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0004969', 'pale kidney', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376581, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0003613', 'abnormal kidney medulla development', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376582, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376583, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376584, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376585, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376586, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0000527', 'abnormal kidney development', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376587, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011534', 'granular kidney', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376588, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376589, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0012024', 'abnormal nephron morphogenesis', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376590, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0002135', 'abnormal kidney morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376591, 'HP:0033911', 'Cortical radial artery medial hypertrophy', 'MP:0011364', 'abnormal metanephros morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(376592, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0003300', 'gastrointestinal ulcer', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376593, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0008786', 'abnormal hindgut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376594, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0003301', 'peptic ulcer', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376595, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0000474', 'abnormal foregut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376596, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0004547', 'esophageal ulcer', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376597, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0003943', 'abnormal hepatobiliary system development', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376598, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0003119', 'abnormal digestive system development', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376599, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0003160', 'abnormal esophagus development', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376600, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0000468', 'abnormal esophageal epithelium morphology', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376601, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0000467', 'abnormal esophagus morphology', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376602, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0002138', 'abnormal hepatobiliary system morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376603, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0000477', 'abnormal intestine morphology', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376604, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0000462', 'abnormal digestive system morphology', 0.48, 5.838135946814261, 1.674008737871713, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376605, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0009705', 'abnormal midgut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376606, 'HP:0034473', 'Increased fecal heptacarboxylporphyrin', 'MP:0010352', 'gastrointestinal tract polyps', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(376607, 'HP:0430010', 'Microblepharia', 'MP:0001296', 'macrophthalmia', 0.42, 6.679863125803252, 1.674975376785392, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376608, 'HP:0430010', 'Microblepharia', 'MP:0005176', 'eyelids fail to open', 0.4583333333333333, 10.404207209241001, 2.1837112837786328, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376609, 'HP:0430010', 'Microblepharia', 'MP:0013395', 'eyelid hypoplasia', 0.4230769230769231, 10.404207209241001, 2.0980419378888553, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376610, 'HP:0430010', 'Microblepharia', 'MP:0009859', 'eye opacity', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376611, 'HP:0430010', 'Microblepharia', 'MP:0001290', 'delayed eyelid opening', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376612, 'HP:0430010', 'Microblepharia', 'MP:0006162', 'thick eyelids', 0.43137254901960786, 10.404207209241001, 2.1185111244405754, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376613, 'HP:0430010', 'Microblepharia', 'MP:0005287', 'narrow eye opening', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376614, 'HP:0430010', 'Microblepharia', 'MP:0030164', 'abnormal inner canthus morphology', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376615, 'HP:0430010', 'Microblepharia', 'MP:0001306', 'small lens', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376616, 'HP:0430010', 'Microblepharia', 'MP:0001297', 'microphthalmia', 0.42, 6.679863125803252, 1.674975376785392, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376617, 'HP:0430010', 'Microblepharia', 'MP:0009265', 'delayed eyelid fusion', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376618, 'HP:0430010', 'Microblepharia', 'MP:0006249', 'phthisis bulbi', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376619, 'HP:0430010', 'Microblepharia', 'MP:0030163', 'abnormal canthus morphology', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376620, 'HP:0430010', 'Microblepharia', 'MP:0008855', 'eye bleb', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376621, 'HP:0430010', 'Microblepharia', 'MP:0006225', 'ocular rupture', 0.45652173913043476, 6.679863125803252, 1.74628254625217, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376622, 'HP:0430010', 'Microblepharia', 'MP:0013451', 'nasolacrimal duct obstruction', 0.41509433962264153, 9.175301480945878, 1.9515675005164117, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(376623, 'HP:0430010', 'Microblepharia', 'MP:0013146', 'eye lesions', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376624, 'HP:0430010', 'Microblepharia', 'MP:0004874', 'abnormal timing of postnatal eyelid opening', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376625, 'HP:0430010', 'Microblepharia', 'MP:0009274', 'buphthalmos', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376626, 'HP:0430010', 'Microblepharia', 'MP:0030167', 'decreased inner canthal distance', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376627, 'HP:0430010', 'Microblepharia', 'MP:0006164', 'ectropion', 0.46808510638297873, 10.404207209241001, 2.206819983226572, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376628, 'HP:0430010', 'Microblepharia', 'MP:0001340', 'abnormal eyelid morphology', 0.4418604651162791, 10.404207209241001, 2.1441100337066126, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376629, 'HP:0430010', 'Microblepharia', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.41304347826086957, 9.175301480945878, 1.9467404649264353, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(376630, 'HP:0430010', 'Microblepharia', 'MP:0013442', 'abnormal Harderian gland size', 0.4074074074074074, 9.175301480945878, 1.9334129896464194, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(376631, 'HP:0430010', 'Microblepharia', 'MP:0010081', 'posterior microphthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376632, 'HP:0430010', 'Microblepharia', 'MP:0013754', 'abnormal ocular surface morphology', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376633, 'HP:0430010', 'Microblepharia', 'MP:0003671', 'abnormal eyelid aperture', 0.46808510638297873, 10.404207209241001, 2.206819983226572, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376634, 'HP:0430010', 'Microblepharia', 'MP:0006198', 'enophthalmos', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376635, 'HP:0430010', 'Microblepharia', 'MP:0011496', 'abnormal head size', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(376636, 'HP:0430010', 'Microblepharia', 'MP:0005262', 'coloboma', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376637, 'HP:0430010', 'Microblepharia', 'MP:0002092', 'abnormal eye morphology', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376638, 'HP:0430010', 'Microblepharia', 'MP:0006165', 'entropion', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376639, 'HP:0430010', 'Microblepharia', 'MP:0013745', 'abnormal eyelid margin morphology', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376640, 'HP:0430010', 'Microblepharia', 'MP:0030166', 'increased inner canthal distance', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376641, 'HP:0430010', 'Microblepharia', 'MP:0013396', 'eyelid hyperplasia', 0.4489795918367347, 10.404207209241001, 2.1613136528948864, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376642, 'HP:0430010', 'Microblepharia', 'MP:0001305', 'enlarged lens', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376643, 'HP:0430010', 'Microblepharia', 'MP:0002697', 'abnormal eye size', 0.45652173913043476, 6.679863125803252, 1.74628254625217, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376644, 'HP:0430010', 'Microblepharia', 'MP:0030165', 'abnormal outer canthus morphology', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376645, 'HP:0430010', 'Microblepharia', 'MP:0003102', 'sclera thinning', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376646, 'HP:0430010', 'Microblepharia', 'MP:0001302', 'eyelids open at birth', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376647, 'HP:0430010', 'Microblepharia', 'MP:0006209', 'calcified intraocular region', 0.45652173913043476, 6.679863125803252, 1.74628254625217, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376648, 'HP:0430010', 'Microblepharia', 'MP:0012535', 'abnormal optic fissure closure', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376649, 'HP:0430010', 'Microblepharia', 'MP:0013744', 'abnormal conjunctival sac morphology', 0.40425531914893614, 9.175301480945878, 1.9259191126492001, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(376650, 'HP:0430010', 'Microblepharia', 'MP:0031290', 'bilateral microphthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376651, 'HP:0430010', 'Microblepharia', 'MP:0005254', 'strabismus', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376652, 'HP:0430010', 'Microblepharia', 'MP:0001299', 'abnormal eye distance/ position', 0.41304347826086957, 6.679863125803252, 1.6610460257886595, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376653, 'HP:0430010', 'Microblepharia', 'MP:0006168', 'epicanthus inversus', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376654, 'HP:0430010', 'Microblepharia', 'MP:0006166', 'eyelid retraction', 0.4583333333333333, 10.404207209241001, 2.1837112837786328, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376655, 'HP:0430010', 'Microblepharia', 'MP:0001286', 'abnormal eye development', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376656, 'HP:0430010', 'Microblepharia', 'MP:0030063', 'abnormal face size', 0.4318181818181818, 5.913369942082322, 1.5979676645064742, 'UPHENO:0087472', 'abnormal face morphology'),
(376657, 'HP:0430010', 'Microblepharia', 'MP:0030041', 'abnormal forehead size', 0.41304347826086957, 5.913369942082322, 1.5628432068256108, 'UPHENO:0087472', 'abnormal face morphology'),
(376658, 'HP:0430010', 'Microblepharia', 'MP:0030071', 'abnormal face shape', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(376659, 'HP:0430010', 'Microblepharia', 'MP:0013449', 'abnormal lacrimal lake morphology', 0.40425531914893614, 9.175301480945878, 1.9259191126492001, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(376660, 'HP:0430010', 'Microblepharia', 'MP:0009651', 'abnormal eyelid development', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376661, 'HP:0430010', 'Microblepharia', 'MP:0008841', 'ruptured lens capsule', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376662, 'HP:0430010', 'Microblepharia', 'MP:0006248', 'lagophthalmos', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376663, 'HP:0430010', 'Microblepharia', 'MP:0009264', 'failure of eyelid fusion', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376664, 'HP:0430010', 'Microblepharia', 'MP:0006163', 'ankyloblepharon filiform', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376665, 'HP:0430010', 'Microblepharia', 'MP:0031289', 'unilateral microphthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376666, 'HP:0430010', 'Microblepharia', 'MP:0003153', 'early eyelid opening', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376667, 'HP:0430010', 'Microblepharia', 'MP:0001344', 'blepharoptosis', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376668, 'HP:0430010', 'Microblepharia', 'MP:0001343', 'pronounced eyelids', 0.43478260869565216, 10.404207209241001, 2.126868202744099, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376669, 'HP:0430010', 'Microblepharia', 'MP:0009263', 'abnormal eyelid fusion', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(376670, 'HP:0430010', 'Microblepharia', 'MP:0013477', 'abnormal cornea limbus morphology', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376671, 'HP:0033051', 'Impaired executive functioning', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376672, 'HP:0033051', 'Impaired executive functioning', 'MP:0002064', 'seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376673, 'HP:0033051', 'Impaired executive functioning', 'MP:0003470', 'abnormal summary potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376674, 'HP:0033051', 'Impaired executive functioning', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376675, 'HP:0033051', 'Impaired executive functioning', 'MP:0003463', 'abnormal single cell response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376676, 'HP:0033051', 'Impaired executive functioning', 'MP:0005403', 'abnormal nerve conduction', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376677, 'HP:0033051', 'Impaired executive functioning', 'MP:0014120', 'focal seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376678, 'HP:0033051', 'Impaired executive functioning', 'MP:0003482', 'increased nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376679, 'HP:0033051', 'Impaired executive functioning', 'MP:0011399', 'increased endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376680, 'HP:0033051', 'Impaired executive functioning', 'MP:0002578', 'impaired ability to fire action potentials', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376681, 'HP:0033051', 'Impaired executive functioning', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376682, 'HP:0033051', 'Impaired executive functioning', 'MP:0021016', 'decreased tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376683, 'HP:0033051', 'Impaired executive functioning', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376684, 'HP:0033051', 'Impaired executive functioning', 'MP:0004994', 'abnormal brain wave pattern', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376685, 'HP:0033051', 'Impaired executive functioning', 'MP:0003465', 'increased single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376686, 'HP:0033051', 'Impaired executive functioning', 'MP:0003464', 'abnormal single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376687, 'HP:0033051', 'Impaired executive functioning', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376688, 'HP:0033051', 'Impaired executive functioning', 'MP:0003880', 'abnormal central pattern generator function', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376689, 'HP:0033051', 'Impaired executive functioning', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376690, 'HP:0033051', 'Impaired executive functioning', 'MP:0003474', 'abnormal summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376691, 'HP:0033051', 'Impaired executive functioning', 'MP:0003476', 'decreased summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376692, 'HP:0033051', 'Impaired executive functioning', 'MP:0013806', 'encephalopathy', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376693, 'HP:0033051', 'Impaired executive functioning', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376694, 'HP:0033051', 'Impaired executive functioning', 'MP:0003475', 'increased summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376695, 'HP:0033051', 'Impaired executive functioning', 'MP:0003480', 'increased nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376696, 'HP:0033051', 'Impaired executive functioning', 'MP:0003466', 'decreased single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376697, 'HP:0033051', 'Impaired executive functioning', 'MP:0004859', 'abnormal synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376698, 'HP:0033051', 'Impaired executive functioning', 'MP:0003469', 'decreased single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376699, 'HP:0033051', 'Impaired executive functioning', 'MP:0009358', 'environmentally induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376700, 'HP:0033051', 'Impaired executive functioning', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376701, 'HP:0033051', 'Impaired executive functioning', 'MP:0003889', 'enhanced sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376702, 'HP:0033051', 'Impaired executive functioning', 'MP:0003472', 'increased summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376703, 'HP:0033051', 'Impaired executive functioning', 'MP:0002635', 'reduced sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376704, 'HP:0033051', 'Impaired executive functioning', 'MP:0021010', 'impaired synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376705, 'HP:0033051', 'Impaired executive functioning', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376706, 'HP:0033051', 'Impaired executive functioning', 'MP:0003635', 'abnormal synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376707, 'HP:0033051', 'Impaired executive functioning', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376708, 'HP:0033051', 'Impaired executive functioning', 'MP:0020371', 'abnormal glymphatic system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376709, 'HP:0033051', 'Impaired executive functioning', 'MP:0005402', 'abnormal action potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376710, 'HP:0033051', 'Impaired executive functioning', 'MP:0003216', 'absence seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376711, 'HP:0033051', 'Impaired executive functioning', 'MP:0003997', 'tonic-clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376712, 'HP:0033051', 'Impaired executive functioning', 'MP:0001752', 'abnormal hypothalamus secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376713, 'HP:0033051', 'Impaired executive functioning', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376714, 'HP:0033051', 'Impaired executive functioning', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376715, 'HP:0033051', 'Impaired executive functioning', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376716, 'HP:0033051', 'Impaired executive functioning', 'MP:0002634', 'abnormal sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376717, 'HP:0033051', 'Impaired executive functioning', 'MP:0000951', 'sporadic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376718, 'HP:0033051', 'Impaired executive functioning', 'MP:0003468', 'increased single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376719, 'HP:0033051', 'Impaired executive functioning', 'MP:0011994', 'increased nerve conduction velocity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376720, 'HP:0033051', 'Impaired executive functioning', 'MP:0011397', 'endoneurial edema', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376721, 'HP:0033051', 'Impaired executive functioning', 'MP:0002826', 'tonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376722, 'HP:0033051', 'Impaired executive functioning', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376723, 'HP:0033051', 'Impaired executive functioning', 'MP:0003633', 'abnormal nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376724, 'HP:0033051', 'Impaired executive functioning', 'MP:0012011', 'febrile seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376725, 'HP:0033051', 'Impaired executive functioning', 'MP:0000920', 'abnormal myelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376726, 'HP:0033051', 'Impaired executive functioning', 'MP:0008814', 'decreased nerve conduction velocity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376727, 'HP:0033051', 'Impaired executive functioning', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376728, 'HP:0033051', 'Impaired executive functioning', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376729, 'HP:0033051', 'Impaired executive functioning', 'MP:0000947', 'convulsive seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376730, 'HP:0033051', 'Impaired executive functioning', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376731, 'HP:0033051', 'Impaired executive functioning', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376732, 'HP:0033051', 'Impaired executive functioning', 'MP:0004513', 'avnosmia', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376733, 'HP:0033051', 'Impaired executive functioning', 'MP:0001912', 'increased cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376734, 'HP:0033051', 'Impaired executive functioning', 'MP:0021015', 'increased tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376735, 'HP:0033051', 'Impaired executive functioning', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376736, 'HP:0033051', 'Impaired executive functioning', 'MP:0003467', 'abnormal single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376737, 'HP:0033051', 'Impaired executive functioning', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376738, 'HP:0033051', 'Impaired executive functioning', 'MP:0003412', 'abnormal afterhyperpolarization', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376739, 'HP:0033051', 'Impaired executive functioning', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376740, 'HP:0033051', 'Impaired executive functioning', 'MP:0003477', 'abnormal nerve fiber response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376741, 'HP:0033051', 'Impaired executive functioning', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376742, 'HP:0033051', 'Impaired executive functioning', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376743, 'HP:0033051', 'Impaired executive functioning', 'MP:0003481', 'decreased nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376744, 'HP:0033051', 'Impaired executive functioning', 'MP:0021009', 'abnormal synaptic physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376745, 'HP:0033051', 'Impaired executive functioning', 'MP:0012006', 'abnormal hippocampus physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376746, 'HP:0033051', 'Impaired executive functioning', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376747, 'HP:0033051', 'Impaired executive functioning', 'MP:0003483', 'decreased nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376748, 'HP:0033051', 'Impaired executive functioning', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376749, 'HP:0033051', 'Impaired executive functioning', 'MP:0000948', 'nonconvulsive seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376750, 'HP:0033051', 'Impaired executive functioning', 'MP:0003473', 'decreased summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376751, 'HP:0033051', 'Impaired executive functioning', 'MP:0006080', 'brain ischemia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376752, 'HP:0033051', 'Impaired executive functioning', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376753, 'HP:0033051', 'Impaired executive functioning', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376754, 'HP:0033051', 'Impaired executive functioning', 'MP:0003471', 'abnormal summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376755, 'HP:0033051', 'Impaired executive functioning', 'MP:0003996', 'clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376756, 'HP:0000568', 'Microphthalmia', 'MP:0003671', 'abnormal eyelid aperture', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376757, 'HP:0000568', 'Microphthalmia', 'MP:0001305', 'enlarged lens', 0.40350877192982454, 6.679863125803252, 1.6417622746768759, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376758, 'HP:0000568', 'Microphthalmia', 'MP:0001297', 'microphthalmia', 0.4716981132075472, 8.581084971325078, 2.011885083757936, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376759, 'HP:0000568', 'Microphthalmia', 'MP:0006228', 'iris atrophy', 0.4098360655737705, 6.679863125803252, 1.654584184032506, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376760, 'HP:0000568', 'Microphthalmia', 'MP:0006225', 'ocular rupture', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376761, 'HP:0000568', 'Microphthalmia', 'MP:0001296', 'macrophthalmia', 0.41818181818181815, 8.581084971325078, 1.8943214392709058, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376762, 'HP:0000568', 'Microphthalmia', 'MP:0013743', 'ciliary body hypoplasia', 0.41935483870967744, 7.117299307471978, 1.7276208794563146, 'UPHENO:0080079', 'aplasia or hypoplasia of anatomical entity'),
(376763, 'HP:0000568', 'Microphthalmia', 'MP:0031499', 'decreased cornea size', 0.4166666666666667, 6.679863125803252, 1.6683154085537968, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376764, 'HP:0000568', 'Microphthalmia', 'MP:0009274', 'buphthalmos', 0.4107142857142857, 8.581084971325078, 1.8773316661291821, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376765, 'HP:0000568', 'Microphthalmia', 'MP:0030167', 'decreased inner canthal distance', 0.41379310344827586, 6.679863125803252, 1.6625526438088596, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376766, 'HP:0000568', 'Microphthalmia', 'MP:0013395', 'eyelid hypoplasia', 0.44642857142857145, 7.117299307471978, 1.7825166934040972, 'UPHENO:0080079', 'aplasia or hypoplasia of anatomical entity'),
(376767, 'HP:0000568', 'Microphthalmia', 'MP:0005287', 'narrow eye opening', 0.41379310344827586, 6.679863125803252, 1.6625526438088596, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376768, 'HP:0000568', 'Microphthalmia', 'MP:0006197', 'ocular hypotelorism', 0.41379310344827586, 6.679863125803252, 1.6625526438088596, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376769, 'HP:0000568', 'Microphthalmia', 'MP:0031289', 'unilateral microphthalmia', 0.46296296296296297, 8.581084971325078, 1.993169466894777, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376770, 'HP:0000568', 'Microphthalmia', 'MP:0030065', 'face hypoplasia', 0.4107142857142857, 7.117299307471978, 1.7097299498117045, 'UPHENO:0080079', 'aplasia or hypoplasia of anatomical entity'),
(376771, 'HP:0000568', 'Microphthalmia', 'MP:0030064', 'small face', 0.4230769230769231, 5.913369942082322, 1.581711212614917, 'UPHENO:0087472', 'abnormal face morphology'),
(376772, 'HP:0000568', 'Microphthalmia', 'MP:0030190', 'small snout', 0.41509433962264153, 5.913369942082322, 1.5667183509019862, 'UPHENO:0087472', 'abnormal face morphology'),
(376773, 'HP:0000568', 'Microphthalmia', 'MP:0030043', 'small forehead', 0.4074074074074074, 5.913369942082322, 1.552143909933821, 'UPHENO:0087472', 'abnormal face morphology'),
(376774, 'HP:0000568', 'Microphthalmia', 'MP:0006249', 'phthisis bulbi', 0.4107142857142857, 8.581084971325078, 1.8773316661291821, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376775, 'HP:0000568', 'Microphthalmia', 'MP:0006209', 'calcified intraocular region', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376776, 'HP:0000568', 'Microphthalmia', 'MP:0031290', 'bilateral microphthalmia', 0.46296296296296297, 8.581084971325078, 1.993169466894777, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376777, 'HP:0000568', 'Microphthalmia', 'MP:0002697', 'abnormal eye size', 0.45098039215686275, 8.581084971325078, 1.9672064115134296, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376778, 'HP:0000568', 'Microphthalmia', 'MP:0006226', 'iris hypoplasia', 0.40625, 7.117299307471978, 1.700412551018279, 'UPHENO:0080079', 'aplasia or hypoplasia of anatomical entity'),
(376779, 'HP:0000568', 'Microphthalmia', 'MP:0001320', 'small pupil', 0.4032258064516129, 6.679863125803252, 1.641186520749061, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376780, 'HP:0000568', 'Microphthalmia', 'MP:0020858', 'corneal epithelium hypoplasia', 0.4126984126984127, 7.117299307471978, 1.7138547566503985, 'UPHENO:0080079', 'aplasia or hypoplasia of anatomical entity'),
(376781, 'HP:0000568', 'Microphthalmia', 'MP:0001306', 'small lens', 0.45454545454545453, 6.679863125803252, 1.7424986142949037, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376782, 'HP:0000568', 'Microphthalmia', 'MP:0003102', 'sclera thinning', 0.45454545454545453, 6.679863125803252, 1.7424986142949037, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376783, 'HP:0000568', 'Microphthalmia', 'MP:0010081', 'posterior microphthalmia', 0.46296296296296297, 8.581084971325078, 1.993169466894777, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(376784, 'HP:0000568', 'Microphthalmia', 'MP:0031317', 'spherophakia', 0.44642857142857145, 6.679863125803252, 1.726870508344716, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(376785, 'HP:0100580', 'Barrett esophagus', 'MP:0000477', 'abnormal intestine morphology', 0.4117647058823529, 8.258419113680198, 1.8440513868647284, 'UPHENO:0076735', 'abnormal alimentary part of gastrointestinal system morphology'),
(376786, 'HP:0007509', 'Patchy hypo- and hyperpigmentation', 'MP:0005408', 'hypopigmentation', 0.45098039215686275, 12.285219173023913, 2.3538039341422077, 'UPHENO:0077877', 'decreased pigmentation in multicellular organism'),
(376787, 'HP:0007509', 'Patchy hypo- and hyperpigmentation', 'MP:0011568', 'decreased foot pigmentation', 0.4838709677419355, 12.607147267911277, 2.4698648847638056, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(376788, 'HP:0007509', 'Patchy hypo- and hyperpigmentation', 'MP:0011277', 'decreased tail pigmentation', 0.46875, 12.607147267911277, 2.430966943796935, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(376789, 'HP:0007509', 'Patchy hypo- and hyperpigmentation', 'MP:0030051', 'increased foot pigmentation', 0.43548387096774194, 12.607147267911277, 2.3431195646168796, 'UPHENO:0074584', 'increased pigmentation in skin of body'),
(376790, 'HP:0007509', 'Patchy hypo- and hyperpigmentation', 'MP:0011276', 'increased tail pigmentation', 0.421875, 12.607147267911277, 2.3062177376930544, 'UPHENO:0074584', 'increased pigmentation in skin of body'),
(376791, 'HP:0007509', 'Patchy hypo- and hyperpigmentation', 'MP:0030926', 'increased skin pigmentation', 0.47368421052631576, 12.607147267911277, 2.4437280128094354, 'UPHENO:0074584', 'increased pigmentation in skin of body'),
(376792, 'HP:0007509', 'Patchy hypo- and hyperpigmentation', 'MP:0030930', 'decreased digit pigmentation', 0.42857142857142855, 12.607147267911277, 2.3244489916578335, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(376793, 'HP:0007509', 'Patchy hypo- and hyperpigmentation', 'MP:0011627', 'decreased skin pigmentation', 0.5263157894736842, 12.607147267911277, 2.5759155008116483, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(376794, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0009203', 'external male genitalia hypoplasia', 0.5918367346938775, 15.022184767190119, 2.981724464229032, 'UPHENO:0081095', 'external male genitalia hypoplasia'),
(376795, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0003611', 'scrotum hypoplasia', 0.5, 12.437222266468964, 2.4937143247041114, 'UPHENO:0087643', 'abnormal external male genitalia morphology'),
(376796, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0009207', 'internal male genitalia hypoplasia', 0.47058823529411764, 9.321745049049028, 2.094445881968226, 'UPHENO:0087802', 'abnormal male reproductive organ morphology'),
(376797, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0009201', 'external male genitalia atrophy', 0.49019607843137253, 14.491670050491338, 2.6652879447955007, 'UPHENO:0068843', 'decreased size of the external male genitalia'),
(376798, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0009200', 'enlarged external male genitalia', 0.43137254901960786, 12.437222266468964, 2.316263428846154, 'UPHENO:0087643', 'abnormal external male genitalia morphology'),
(376799, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0009202', 'small external male genitalia', 0.5208333333333334, 14.491670050491338, 2.7473159297693157, 'UPHENO:0068843', 'decreased size of the external male genitalia'),
(376800, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0011772', 'genital tubercle hypoplasia', 0.4230769230769231, 9.95849009187273, 2.0526098865984106, 'UPHENO:0002595', 'abnormal external genitalia'),
(376801, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0001150', 'enlarged scrotum', 0.4074074074074074, 12.437222266468964, 2.251003438231892, 'UPHENO:0087643', 'abnormal external male genitalia morphology'),
(376802, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0003609', 'small scrotum', 0.46153846153846156, 12.437222266468964, 2.3958832255930136, 'UPHENO:0087643', 'abnormal external male genitalia morphology'),
(376803, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0005188', 'small penis', 0.42857142857142855, 12.437222266468964, 2.308730844901801, 'UPHENO:0087643', 'abnormal external male genitalia morphology'),
(376804, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0004932', 'epididymis hypoplasia', 0.42105263157894735, 9.321745049049028, 1.9811474664471893, 'UPHENO:0087802', 'abnormal male reproductive organ morphology'),
(376805, 'HP:0000050', 'Hypoplastic male external genitalia', 'MP:0009214', 'vas deferens hypoplasia', 0.43636363636363634, 9.321745049049028, 2.0168466889820253, 'UPHENO:0087802', 'abnormal male reproductive organ morphology'),
(376806, 'HP:0040035', 'Abnormality of the fourth metatarsal bone', 'MP:0030825', 'decreased femur size', 0.42028985507246375, 7.694257931681313, 1.7982821110705889, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(376807, 'HP:0040035', 'Abnormality of the fourth metatarsal bone', 'MP:0030823', 'increased femur size', 0.42028985507246375, 7.694257931681313, 1.7982821110705889, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(376808, 'HP:0040035', 'Abnormality of the fourth metatarsal bone', 'MP:0030827', 'femur fracture', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(376809, 'HP:0040035', 'Abnormality of the fourth metatarsal bone', 'MP:0004642', 'fused metatarsal bones', 0.4507042253521127, 11.548253578857707, 2.281413308330787, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(376810, 'HP:0040035', 'Abnormality of the fourth metatarsal bone', 'MP:0008158', 'increased diameter of femur', 0.4084507042253521, 7.694257931681313, 1.7727732710887576, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(376811, 'HP:0040035', 'Abnormality of the fourth metatarsal bone', 'MP:0008152', 'decreased diameter of femur', 0.4084507042253521, 7.694257931681313, 1.7727732710887576, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(376812, 'HP:0040035', 'Abnormality of the fourth metatarsal bone', 'MP:0004635', 'short metatarsal bones', 0.4507042253521127, 11.548253578857707, 2.281413308330787, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(376813, 'HP:0040035', 'Abnormality of the fourth metatarsal bone', 'MP:0004641', 'elongated metatarsal bones', 0.4507042253521127, 11.548253578857707, 2.281413308330787, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(376814, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0020835', 'abnormal circulating citrulline level', 0.47368421052631576, 11.700256672302759, 2.35419345950476, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(376815, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030652', 'abnormal circulating glutathione level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376816, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030726', 'abnormal circulating valine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376817, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030669', 'abnormal circulating phenylalanine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376818, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4716981132075472, 9.920646740728058, 2.1632268372503214, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376819, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030666', 'abnormal circulating proline level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376820, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030686', 'abnormal circulating cystathionine level', 0.4576271186440678, 11.700256672302759, 2.313947870705375, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(376821, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030654', 'abnormal circulating glycine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376822, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030649', 'abnormal circulating ornithine level', 0.4576271186440678, 11.700256672302759, 2.313947870705375, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(376823, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0003977', 'abnormal circulating carnitine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376824, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0013722', 'abnormal circulating tyrosine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376825, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030749', 'abnormal circulating leucine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376826, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.45454545454545453, 9.920646740728058, 2.1235312293792896, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376827, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030637', 'abnormal circulating taurine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376828, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030738', 'abnormal circulating glutamic acid level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376829, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030625', 'increased circulating cysteine level', 0.43859649122807015, 9.920646740728058, 2.0859436356710397, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376830, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030660', 'abnormal circulating arginine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376831, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030708', 'abnormal circulating glutamine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376832, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0010063', 'abnormal circulating creatine level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376833, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0005476', 'abnormal circulating triiodothyronine level', 0.421875, 11.700256672302759, 2.2217213559822766, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(376834, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0011651', 'abnormal circulating histidine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376835, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.45454545454545453, 9.920646740728058, 2.1235312293792896, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376836, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0005475', 'abnormal circulating thyroxine level', 0.42857142857142855, 11.700256672302759, 2.239284643965832, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(376837, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030702', 'abnormal circulating threonine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376838, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030626', 'decreased circulating cysteine level', 0.43859649122807015, 9.920646740728058, 2.0859436356710397, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376839, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030714', 'abnormal circulating isoleucine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376840, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030693', 'abnormal circulating serine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376841, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0006076', 'abnormal circulating homocysteine level', 0.47368421052631576, 11.700256672302759, 2.35419345950476, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(376842, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0005328', 'abnormal circulating creatinine level', 0.43859649122807015, 9.920646740728058, 2.0859436356710397, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376843, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030643', 'abnormal circulating methionine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376844, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.46296296296296297, 9.920646740728058, 2.143103359522429, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376845, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030672', 'abnormal circulating alanine level', 0.43859649122807015, 9.920646740728058, 2.0859436356710397, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376846, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030717', 'abnormal circulating lysine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(376847, 'HP:0033109', 'Abnormal circulating non-proteinogenic amino acid concentration', 'MP:0030680', 'abnormal circulating hydroxyproline level', 0.45, 11.700256672302759, 2.294583949768725, 'UPHENO:0082860', 'abnormal blood non-proteinogenic amino acid level'),
(376848, 'HP:0031834', 'Aortopulmonary collateral arteries', 'MP:0010522', 'calcified aorta', 0.40425531914893614, 9.58108497132508, 1.9680458741797906, 'UPHENO:0076809', 'abnormal aorta morphology'),
(376849, 'HP:0031834', 'Aortopulmonary collateral arteries', 'MP:0006133', 'calcified artery', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(376850, 'HP:0031834', 'Aortopulmonary collateral arteries', 'MP:0012562', 'blood vessel degeneration', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(376851, 'HP:0031834', 'Aortopulmonary collateral arteries', 'MP:0004938', 'dilated vasculature', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(376852, 'HP:0031834', 'Aortopulmonary collateral arteries', 'MP:0000265', 'blood vessel atresia', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(376853, 'HP:0031834', 'Aortopulmonary collateral arteries', 'MP:0020327', 'abnormal capillary branching pattern', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(376854, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376855, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376856, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376857, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002914', 'abnormal endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376858, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376859, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376860, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376861, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376862, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014178', 'increased brain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376863, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376864, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376865, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376866, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376867, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014252', 'abnormal paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376868, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014255', 'increased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376869, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376870, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376871, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376872, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376873, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376874, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003472', 'increased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376875, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376876, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376877, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376878, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376879, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376880, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376881, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002635', 'reduced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376882, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010050', 'hypermyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376883, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003480', 'increased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376884, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376885, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376886, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376887, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376888, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376889, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376890, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376891, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376892, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376893, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004768', 'abnormal axonal transport', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376894, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376895, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376896, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376897, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376898, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376899, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376900, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376901, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376902, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014120', 'focal seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376903, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376904, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003486', 'abnormal channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376905, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376906, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003474', 'abnormal summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376907, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376908, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376909, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376910, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376911, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376912, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376913, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376914, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376915, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376916, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376917, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003482', 'increased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376918, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376919, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376920, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376921, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376922, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376923, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376924, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376925, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009967', 'abnormal neuron proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376926, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004495', 'decreased synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376927, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376928, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376929, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003088', 'abnormal prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376930, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001499', 'abnormal kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376931, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376932, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376933, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376934, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003217', 'increased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376935, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003485', 'abnormal channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376936, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001898', 'abnormal long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376937, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376938, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021010', 'impaired synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376939, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376940, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003487', 'increased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376941, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376942, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376943, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376944, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376945, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376946, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376947, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376948, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376949, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003219', 'increased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376950, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003475', 'increased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376951, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006080', 'brain ischemia', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376952, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003490', 'decreased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376953, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376954, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376955, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002193', 'minimal clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376956, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013182', 'increased spinal cord apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376957, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376958, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376959, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011994', 'increased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376960, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376961, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376962, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001496', 'audiogenic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376963, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376964, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376965, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376966, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376967, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376968, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376969, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376970, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376971, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376972, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376973, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376974, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376975, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376976, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004835', 'abnormal miniature endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376977, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376978, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376979, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021001', 'impaired neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376980, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376981, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000920', 'abnormal myelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376982, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376983, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376984, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376985, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376986, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376987, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376988, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003889', 'enhanced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376989, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376990, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376991, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376992, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376993, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376994, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(376995, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376996, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008814', 'decreased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376997, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376998, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(376999, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377000, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377001, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377002, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377003, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377004, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377005, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377006, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377007, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377008, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377009, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377010, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377011, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377012, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014254', 'increased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377013, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377014, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377015, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377016, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377017, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377018, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377019, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377020, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377021, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377022, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377023, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377024, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377025, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013806', 'encephalopathy', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377026, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002922', 'decreased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377027, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003465', 'increased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377028, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377029, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377030, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003488', 'decreased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377031, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377032, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377033, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001500', 'decreased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377034, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377035, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377036, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377037, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377038, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003476', 'decreased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377039, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377040, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006060', 'increased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377041, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002917', 'decreased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377042, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377043, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004513', 'avnosmia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377044, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005402', 'abnormal action potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377045, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377046, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001473', 'reduced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377047, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377048, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377049, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377050, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377051, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001900', 'impaired synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377052, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377053, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377054, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003633', 'abnormal nervous system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377055, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377056, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377057, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377058, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003467', 'abnormal single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377059, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377060, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377061, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377062, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003466', 'decreased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377063, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004994', 'abnormal brain wave pattern', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377064, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377065, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003463', 'abnormal single cell response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377066, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377067, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377068, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377069, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377070, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377071, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014253', 'decreased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377072, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008921', 'increased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377073, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000921', 'demyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377074, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377075, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002207', 'abnormal long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377076, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377077, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377078, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000951', 'sporadic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377079, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377080, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377081, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377082, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377083, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377084, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377085, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030990', 'nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377086, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377087, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377088, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377089, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377090, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011397', 'endoneurial edema', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377091, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377092, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377093, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377094, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377095, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377096, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377097, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377098, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377099, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377100, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377101, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377102, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003996', 'clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377103, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377104, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377105, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377106, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377107, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003464', 'abnormal single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377108, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377109, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377110, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377111, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013438', 'dysmyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377112, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377113, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003990', 'decreased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377114, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377115, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377116, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377117, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377118, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377119, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377120, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377121, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377122, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377123, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003473', 'decreased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377124, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377125, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377126, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377127, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377128, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377129, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377130, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003471', 'abnormal summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377131, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377132, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377133, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377134, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377135, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003997', 'tonic-clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377136, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377137, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377138, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377139, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003880', 'abnormal central pattern generator function', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377140, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377141, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377142, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377143, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377144, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377145, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012006', 'abnormal hippocampus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377146, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377147, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377148, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377149, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377150, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377151, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002195', 'psychomotor seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377152, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377153, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377154, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377155, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377156, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377157, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377158, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377159, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377160, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377161, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377162, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377163, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377164, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377165, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009358', 'environmentally induced seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377166, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002578', 'impaired ability to fire action potentials', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377167, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377168, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377169, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377170, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377171, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377172, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377173, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377174, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377175, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377176, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021009', 'abnormal synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377177, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377178, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377179, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377180, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377181, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377182, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377183, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377184, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377185, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377186, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377187, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377188, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377189, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377190, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377191, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009141', 'increased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377192, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377193, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377194, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377195, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377196, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377197, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004811', 'abnormal neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377198, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377199, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377200, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377201, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005403', 'abnormal nerve conduction', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377202, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377203, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377204, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377205, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377206, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377207, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006082', 'CNS inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377208, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377209, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002064', 'seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377210, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009142', 'decreased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377211, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377212, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377213, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377214, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377215, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377216, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377217, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377218, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377219, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377220, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377221, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377222, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377223, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008840', 'abnormal spike wave discharge', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377224, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001475', 'reduced long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377225, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377226, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377227, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377228, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377229, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377230, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377231, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014179', 'abnormal blood-retina barrier function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377232, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377233, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003489', 'increased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377234, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377235, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003635', 'abnormal synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377236, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377237, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377238, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003477', 'abnormal nerve fiber response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377239, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377240, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377241, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377242, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377243, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377244, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377245, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377246, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377247, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377248, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377249, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377250, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377251, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002634', 'abnormal sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377252, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377253, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377254, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377255, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377256, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000948', 'nonconvulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377257, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377258, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377259, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377260, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377261, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377262, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377263, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377264, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377265, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003008', 'enhanced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377266, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377267, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003469', 'decreased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377268, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377269, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002916', 'increased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377270, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004859', 'abnormal synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377271, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003470', 'abnormal summary potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377272, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377273, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377274, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377275, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377276, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377277, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377278, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377279, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002826', 'tonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377280, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0021015', 'increased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377281, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003484', 'abnormal channel response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377282, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377283, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377284, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377285, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377286, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0000947', 'convulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377287, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377288, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002923', 'increased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377289, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003468', 'increased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377290, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377291, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377292, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377293, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377294, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377295, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0003202', 'abnormal neuron apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377296, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377297, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377298, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377299, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377300, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377301, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377302, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377303, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377304, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377305, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006058', 'decreased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377306, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377307, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377308, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377309, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377310, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377311, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377312, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377313, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377314, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377315, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377316, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377317, 'HP:0025053', 'Elevated brain N-acetyl aspartate level by MRS', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377318, 'HP:0032957', 'Dysmorphic hematuria', 'MP:0005161', 'hematuria', 0.4583333333333333, 15.384754846574829, 2.6554370584419424, 'UPHENO:0056192', 'abnormally increased number of blood in the urine'),
(377319, 'HP:0034980', 'Synkinesis', 'MP:0003633', 'abnormal nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(377320, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377321, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377322, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377323, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377324, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377325, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377326, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377327, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377328, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377329, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377330, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377331, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377332, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377333, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377334, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377335, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377336, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377337, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377338, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377339, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377340, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377341, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377342, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377343, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377344, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377345, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377346, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377347, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377348, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377349, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377350, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377351, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377352, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377353, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377354, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377355, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377356, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377357, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377358, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377359, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377360, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377361, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377362, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377363, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377364, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377365, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377366, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377367, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377368, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377369, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377370, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377371, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377372, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377373, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377374, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377375, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377376, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377377, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377378, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377379, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377380, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377381, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377382, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377383, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377384, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377385, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377386, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377387, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377388, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377389, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377390, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377391, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377392, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377393, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377394, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377395, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377396, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377397, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377398, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377399, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377400, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377401, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377402, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377403, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377404, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377405, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377406, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377407, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377408, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377409, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377410, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377411, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377412, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377413, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377414, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377415, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377416, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377417, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377418, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377419, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377420, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377421, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377422, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377423, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377424, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377425, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377426, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377427, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377428, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377429, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377430, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377431, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377432, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377433, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377434, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377435, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377436, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377437, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377438, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377439, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377440, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377441, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377442, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377443, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377444, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377445, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377446, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377447, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377448, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377449, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377450, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377451, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377452, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377453, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377454, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377455, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377456, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377457, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377458, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377459, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377460, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377461, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377462, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377463, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377464, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377465, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377466, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377467, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377468, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377469, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377470, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377471, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377472, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377473, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377474, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377475, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377476, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377477, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377478, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377479, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377480, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377481, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377482, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377483, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377484, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377485, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377486, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377487, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377488, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377489, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377490, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377491, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377492, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377493, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377494, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377495, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377496, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377497, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377498, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377499, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377500, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377501, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377502, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377503, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377504, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377505, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377506, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377507, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377508, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377509, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377510, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377511, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377512, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377513, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377514, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377515, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377516, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377517, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377518, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377519, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377520, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377521, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377522, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377523, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377524, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377525, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377526, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377527, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377528, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377529, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377530, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377531, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377532, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377533, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377534, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377535, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377536, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377537, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377538, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377539, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377540, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377541, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377542, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377543, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377544, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377545, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377546, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377547, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377548, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377549, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377550, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377551, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377552, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377553, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377554, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377555, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377556, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377557, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377558, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377559, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377560, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377561, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377562, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377563, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377564, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377565, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377566, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377567, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377568, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377569, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377570, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377571, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377572, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377573, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377574, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377575, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377576, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377577, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377578, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377579, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377580, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377581, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377582, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377583, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377584, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377585, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377586, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377587, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377588, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377589, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377590, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377591, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377592, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377593, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377594, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377595, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377596, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377597, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377598, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377599, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377600, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377601, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377602, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377603, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377604, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377605, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377606, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377607, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377608, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377609, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377610, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377611, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377612, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377613, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377614, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377615, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377616, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377617, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377618, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377619, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377620, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377621, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377622, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377623, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377624, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377625, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377626, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377627, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377628, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377629, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377630, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377631, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377632, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377633, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377634, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377635, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377636, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377637, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377638, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377639, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377640, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377641, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377642, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377643, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377644, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377645, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377646, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377647, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377648, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377649, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377650, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377651, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377652, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377653, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377654, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377655, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377656, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377657, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377658, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377659, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377660, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377661, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377662, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377663, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377664, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377665, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377666, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377667, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377668, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377669, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377670, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377671, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377672, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377673, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377674, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377675, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377676, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377677, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377678, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377679, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377680, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377681, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377682, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377683, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377684, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377685, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377686, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377687, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377688, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377689, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377690, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377691, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377692, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377693, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377694, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377695, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377696, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377697, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377698, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377699, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377700, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377701, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377702, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377703, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377704, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377705, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377706, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377707, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377708, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377709, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377710, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377711, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377712, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377713, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377714, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377715, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377716, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377717, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377718, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377719, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377720, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377721, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377722, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377723, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377724, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377725, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377726, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377727, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377728, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377729, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377730, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377731, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377732, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377733, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377734, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377735, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377736, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377737, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377738, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377739, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377740, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377741, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377742, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377743, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377744, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377745, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377746, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377747, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377748, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377749, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377750, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377751, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377752, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377753, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377754, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377755, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377756, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377757, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377758, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377759, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377760, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377761, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377762, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377763, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377764, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377765, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377766, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377767, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377768, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377769, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377770, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377771, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377772, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377773, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377774, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377775, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377776, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377777, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377778, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377779, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377780, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377781, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377782, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377783, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377784, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377785, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377786, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377787, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377788, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377789, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377790, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377791, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377792, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377793, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377794, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377795, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377796, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377797, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377798, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377799, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377800, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377801, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377802, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377803, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377804, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377805, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377806, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377807, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377808, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377809, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377810, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377811, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377812, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377813, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377814, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377815, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377816, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377817, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377818, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377819, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377820, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377821, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377822, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377823, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377824, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377825, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377826, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377827, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377828, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377829, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377830, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377831, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377832, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377833, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377834, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377835, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377836, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377837, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377838, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377839, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377840, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377841, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377842, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377843, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377844, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377845, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377846, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377847, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377848, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377849, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377850, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377851, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377852, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377853, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377854, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377855, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377856, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377857, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377858, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377859, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377860, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377861, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377862, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377863, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377864, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377865, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377866, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377867, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377868, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377869, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377870, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377871, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(377872, 'HP:0005416', 'Decreased circulating complement factor B concentration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(377873, 'HP:0001574', 'Abnormality of the integument', 'MP:0013800', 'abnormal pericardial fat pad morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377874, 'HP:0001574', 'Abnormality of the integument', 'MP:0013558', 'abnormal exocrine gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377875, 'HP:0001574', 'Abnormality of the integument', 'MP:0014063', 'Lafora bodies', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377876, 'HP:0001574', 'Abnormality of the integument', 'MP:0000731', 'increased collagen deposition in the muscles', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377877, 'HP:0001574', 'Abnormality of the integument', 'MP:0031106', 'abnormal susceptibility to pulmonary hyaline membrane formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377878, 'HP:0001574', 'Abnormality of the integument', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377879, 'HP:0001574', 'Abnormality of the integument', 'MP:0000751', 'myopathy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377880, 'HP:0001574', 'Abnormality of the integument', 'MP:0001542', 'abnormal bone strength', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377881, 'HP:0001574', 'Abnormality of the integument', 'MP:3000001', 'abnormal gastrula morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377882, 'HP:0001574', 'Abnormality of the integument', 'MP:0000285', 'abnormal heart valve morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377883, 'HP:0001574', 'Abnormality of the integument', 'MP:0002138', 'abnormal hepatobiliary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377884, 'HP:0001574', 'Abnormality of the integument', 'MP:0011018', 'pulmonary hyaline membrane formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377885, 'HP:0001574', 'Abnormality of the integument', 'MP:0000423', 'delayed hair regrowth', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377886, 'HP:0001574', 'Abnormality of the integument', 'MP:0011187', 'abnormal parietal endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377887, 'HP:0001574', 'Abnormality of the integument', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377888, 'HP:0001574', 'Abnormality of the integument', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(377889, 'HP:0001574', 'Abnormality of the integument', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377890, 'HP:0001574', 'Abnormality of the integument', 'MP:0000313', 'abnormal cell death', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377891, 'HP:0001574', 'Abnormality of the integument', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.43478260869565216, 6.509554027552121, 1.6823319772103247, 'UPHENO:0002635', 'abnormal integument'),
(377892, 'HP:0001574', 'Abnormality of the integument', 'MP:0009441', 'delayed skin barrier formation', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377893, 'HP:0001574', 'Abnormality of the integument', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377894, 'HP:0001574', 'Abnormality of the integument', 'MP:0006080', 'brain ischemia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377895, 'HP:0001574', 'Abnormality of the integument', 'MP:0002653', 'abnormal ependyma morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377896, 'HP:0001574', 'Abnormality of the integument', 'MP:0003632', 'abnormal nervous system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377897, 'HP:0001574', 'Abnormality of the integument', 'MP:0013806', 'encephalopathy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377898, 'HP:0001574', 'Abnormality of the integument', 'MP:0012684', 'abnormal pleural cavity morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377899, 'HP:0001574', 'Abnormality of the integument', 'MP:0010695', 'abnormal blood pressure regulation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377900, 'HP:0001574', 'Abnormality of the integument', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377901, 'HP:0001574', 'Abnormality of the integument', 'MP:0001985', 'abnormal gustatory system physiology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377902, 'HP:0001574', 'Abnormality of the integument', 'MP:0002163', 'abnormal gland morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377903, 'HP:0001574', 'Abnormality of the integument', 'MP:0013126', 'teat swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377904, 'HP:0001574', 'Abnormality of the integument', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377905, 'HP:0001574', 'Abnormality of the integument', 'MP:0003300', 'gastrointestinal ulcer', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377906, 'HP:0001574', 'Abnormality of the integument', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377907, 'HP:0001574', 'Abnormality of the integument', 'MP:0020412', 'abnormal amnion physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377908, 'HP:0001574', 'Abnormality of the integument', 'MP:0002210', 'abnormal sex determination', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377909, 'HP:0001574', 'Abnormality of the integument', 'MP:0006301', 'abnormal mesenchyme morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377910, 'HP:0001574', 'Abnormality of the integument', 'MP:0001210', 'skin ridges', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377911, 'HP:0001574', 'Abnormality of the integument', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377912, 'HP:0001574', 'Abnormality of the integument', 'MP:0003652', 'abnormal skin turgor', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377913, 'HP:0001574', 'Abnormality of the integument', 'MP:0013125', 'thorax swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377914, 'HP:0001574', 'Abnormality of the integument', 'MP:0010426', 'abnormal heart and great artery attachment', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377915, 'HP:0001574', 'Abnormality of the integument', 'MP:0001243', 'abnormal dermal layer morphology', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377916, 'HP:0001574', 'Abnormality of the integument', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(377917, 'HP:0001574', 'Abnormality of the integument', 'MP:0005623', 'abnormal meninges morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377918, 'HP:0001574', 'Abnormality of the integument', 'MP:0010206', 'pigment incontinence', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(377919, 'HP:0001574', 'Abnormality of the integument', 'MP:0009407', 'increased skeletal muscle fiber density', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377920, 'HP:0001574', 'Abnormality of the integument', 'MP:0009379', 'abnormal foot pigmentation', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(377921, 'HP:0001574', 'Abnormality of the integument', 'MP:0008816', 'petechiae', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377922, 'HP:0001574', 'Abnormality of the integument', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377923, 'HP:0001574', 'Abnormality of the integument', 'MP:0013069', 'limb wound', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377924, 'HP:0001574', 'Abnormality of the integument', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377925, 'HP:0001574', 'Abnormality of the integument', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377926, 'HP:0001574', 'Abnormality of the integument', 'MP:0002420', 'abnormal adaptive immunity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377927, 'HP:0001574', 'Abnormality of the integument', 'MP:0012514', 'pectus excavatum', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377928, 'HP:0001574', 'Abnormality of the integument', 'MP:0013136', 'genital discharge', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377929, 'HP:0001574', 'Abnormality of the integument', 'MP:0009827', 'skin detachment', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377930, 'HP:0001574', 'Abnormality of the integument', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377931, 'HP:0001574', 'Abnormality of the integument', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377932, 'HP:0001574', 'Abnormality of the integument', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377933, 'HP:0001574', 'Abnormality of the integument', 'MP:0009697', 'abnormal copulation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377934, 'HP:0001574', 'Abnormality of the integument', 'MP:0020981', 'abnormal immune system development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377935, 'HP:0001574', 'Abnormality of the integument', 'MP:0011043', 'abnormal lung elastance', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377936, 'HP:0001574', 'Abnormality of the integument', 'MP:0011046', 'abnormal lung tissue damping', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377937, 'HP:0001574', 'Abnormality of the integument', 'MP:0002098', 'abnormal vibrissa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377938, 'HP:0001574', 'Abnormality of the integument', 'MP:0000566', 'synostosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377939, 'HP:0001574', 'Abnormality of the integument', 'MP:0004998', 'decreased CNS synapse formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377940, 'HP:0001574', 'Abnormality of the integument', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4166666666666667, 6.509554027552121, 1.6469104948802522, 'UPHENO:0002635', 'abnormal integument'),
(377941, 'HP:0001574', 'Abnormality of the integument', 'MP:0000428', 'abnormal craniofacial morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377942, 'HP:0001574', 'Abnormality of the integument', 'MP:0001201', 'translucent skin', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377943, 'HP:0001574', 'Abnormality of the integument', 'MP:0002111', 'abnormal tail morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377944, 'HP:0001574', 'Abnormality of the integument', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377945, 'HP:0001574', 'Abnormality of the integument', 'MP:0001208', 'blistering', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377946, 'HP:0001574', 'Abnormality of the integument', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.43478260869565216, 6.509554027552121, 1.6823319772103247, 'UPHENO:0002635', 'abnormal integument'),
(377947, 'HP:0001574', 'Abnormality of the integument', 'MP:0030988', 'dysosmia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377948, 'HP:0001574', 'Abnormality of the integument', 'MP:0020130', 'abnormal total fat pad weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377949, 'HP:0001574', 'Abnormality of the integument', 'MP:0002932', 'abnormal joint morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377950, 'HP:0001574', 'Abnormality of the integument', 'MP:0013118', 'swellings', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377951, 'HP:0001574', 'Abnormality of the integument', 'MP:0013120', 'urogenital swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377952, 'HP:0001574', 'Abnormality of the integument', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377953, 'HP:0001574', 'Abnormality of the integument', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377954, 'HP:0001574', 'Abnormality of the integument', 'MP:0000267', 'abnormal heart development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377955, 'HP:0001574', 'Abnormality of the integument', 'MP:0003115', 'abnormal respiratory system development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377956, 'HP:0001574', 'Abnormality of the integument', 'MP:0013221', 'pancreatic acinar-to-ductal metaplasia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377957, 'HP:0001574', 'Abnormality of the integument', 'MP:0004512', 'anosmia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377958, 'HP:0001574', 'Abnormality of the integument', 'MP:0012496', 'abnormal pleuropericardial membrane morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377959, 'HP:0001574', 'Abnormality of the integument', 'MP:0000778', 'abnormal nervous system tract morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377960, 'HP:0001574', 'Abnormality of the integument', 'MP:0001216', 'abnormal epidermal layer morphology', 0.45454545454545453, 6.509554027552121, 1.7201419111055556, 'UPHENO:0002635', 'abnormal integument'),
(377961, 'HP:0001574', 'Abnormality of the integument', 'MP:0002998', 'abnormal bone remodeling', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(377962, 'HP:0001574', 'Abnormality of the integument', 'MP:0003795', 'abnormal bone structure', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
